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ABSTRACT  
Objective: Examine cardiovascular response to OMT via central and peripheral 
measurements. Methods: Central and peripheral cardiovascular signals of 
asymptomatic human subjects were monitored during a procedure with alternating 
rest and active phases. Active phases included systemic perturbations and 
application of controlled vertebral pressure (OMT) by an experienced osteopathic 
physician. Pulse plethysmograph and laser Doppler flow sensors measured peripheral 
flow from index and middle fingers bilaterally. A three-lead EKG monitored cardiac 
activity. The biosignals were recorded continuously, in real time, and analyzed in 
time and frequency domains. Results from the control group (n=11), without OMT, 
and active group (n=16), with OMT, were compared. Peripheral (n=5) and central 
responders (n=6), subsets of the active group showing stronger peripheral or central 
response, were examined. In an additional effort, a modified clinical device recorded 
spectral Doppler ultrasound signals of the radial and dorsalis pedis arteries of 
clinically asymptomatic human subjects. Controlled physiologic provocations (limb 
occlusion and elevation), were performed. Time domain and spectral analyses were 
completed. Results: In the human subject study, the time wave characteristics and 
spectral analysis resulted in similar trends. Peripheral blood flow attenuated in the 
control group over time, while it was maintained in the active group, and increased 
specifically during OMT in the responder groups. Heart rate remained around 65 BPM 
in the control group, fluctuated between 64-68 BPM in the active group, and dropped 
4 and 3 BPM in the peripheral and central responder groups, respectively. The effect 
in the OMT group was statistically significant compared to no-OMT, however, was not 
statistically significant within-groups. For the preliminary spectral ultrasound Doppler 
study, segmental flow was successfully monitored. A prototype "Quick Assessment" 
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tool was developed, providing instant post-processing results for clinical use. 
Conclusions: OMT along the vertebral column may influence autonomic processes 
that regulate heart rate and peripheral vascular flow. 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
OMT and the Cardiovascular System 
Osteopathic manipulative treatments (OMT) aim to improve and maintain the 
body’s natural abilities to sustain health by balancing the autonomic regulatory 
processes (sympathetic and parasympathetic activity) (Henley 2008)(Tozzi 
2012)(Chila 2010).  Skin blood flow and cardiac activity assessments are often used 
as a measure of autonomic response (Foo 2009) (Grimm 2005) (Shibasaki 2009).  In 
the present study, cardiovascular response to OMT in asymptomatic human subjects 
was investigated. 
Motivation:  OMT Function Is Not Clearly Understood 
Osteopathic medicine is a well-established modern practice in the US today.  
Due to over a century of positive clinical outcomes and anecdotal evidence, the 
practice has maintained its good standing as a mainstream holistic approach to 
healthcare.  However, physiological mechanistic changes induced by the distinct 
manual techniques, known as OMT, are not well understood.  Demand for this 
understanding is growing in practicing osteopathic physicians, known as diplomats of 
osteopathy (DO), patients, and the scientific community more and more (Gevitz 
2001).  As such there is a need for good evidence-based scientific research (Johnson 
2001) (Gevitz 2001) (Early 2010). 
Rational For Measuring Cardiovascular Response 
Irregular or impaired function is referred to as somatic dysfunction in the 
osteopathic medical field.  Somatic dysfunction is evident in tissue texture changes, 
asymmetry, restricted range of motion and tenderness, or TART (Brolinson 2008).  
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Sites of somatic dysfunction are identified through palpation and treated with a 
variety of OMT methods including muscle and joint mobilization, stretching, strain 
and counter-strain, pressure and resistance techniques (Estrada 2010) (Brolinson 
2008).  
Somatic dysfunction is a result of an imbalance in the somatovisceral or 
viscerasomatic neural pathways, whereby an interneuron may become over excitable 
and negatively impact multiple systems and functions (Chila 2010).  This dysfunction 
causes tissues to swell and leads to TART (Northop 1979).  Internal pressures from 
swelling tissues cause circulatory vessels to be occluded, increasing systemic 
resistance.  An increase in systemic resistance results in poor blood supply whose 
negative impacts are two fold; first, as lack of nutrients to the tissue and second, as 
buildup of metabolic waste in the tissue (Chila 2010) (Northop 1979) (Rivers 2007).  
This combination results in degraded tissue health that can lead to downstream 
functional impairments.  Increased systemic resistance also leads to an increase in 
heart rate.  As such, osteopathic medicine focuses on alleviating systemic resistance 
so as to “optimize blood circulation to restore and maintain health” (Brolinson 2008).   
Figure 1 illustrates somatic dysfunction, circulation and OMT in a block diagram.   
Since optimizing circulation is a focus in osteopathic philosophy, the following 
hypotheses were studied:   
Hypothesis 1:  OMT will produce a change from baseline in peripheral flow. 
Hypothesis 2:  OMT will produce a change from baseline in cardiac activity.   
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Figure 1:  Somatic dysfunction, OMT and circulation 
Goals 
The goals of this project were as follows:   
1. To establish a baseline expectation of physiologic response to OMT:  This was 
achieved by selecting asymptomatic subjects, without tobacco or caffeine use.  Also, 
non-invasive sensors were used to minimize interference.  Furthermore, since the 
systems of the body are highly integrated, and autonomic and non-autonomic 
processes work in concert, multiple biosignals from central and peripheral 
perspectives were measured.  Data was also acquired bilaterally. 
2. To develop a reproducible and reliable test and measurement methodology 
for future OMT research:  This was accomplished in two experiments which are 
described in proceeding chapters.  The first was a quasi-controlled, single blind study 
in which the subject underwent an OMT protocol.  Peripheral blood flow and cardiac 
activity biosignals were acquired.  In the second study, a technique for measuring 
segmental arterial flow using spectral Doppler ultrasound was developed. 
 4 
3. Develop physiologic evaluation for clinical procedure assessment:  This was 
achieved by analyzing the biosignals in the time and frequency domain using scripts 
coded in Matlab. 
4. Determine significance of results, if any:  This was accomplished with 
statistical analysis. 
Contributions 
The contributions of this study were as follows:  
- Provided quantitative subjective data to further the understanding of 
physiologic mechanisms and the role OMT has in it. 
- Developed a nascent methodology of test and measurement for furthering 
osteopathic medical research at A. T. Still University, School of Osteopathic 
Medicine in Mesa, Arizona 
- Demonstrated physiologic asymmetries bilaterally and in the upper and lower 
extremities. 
- Demonstrated blood flow waveform characteristics that have clinical 
significance.  
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- CHAPTER 2 
- LITERATURE 
OMT Development 
Osteopathic medicine was developed by Dr. Andrew Taylor Still (1828-1917), 
a physician, inventor and legislator during Civil War era America, in response to 
losing his three children to spinal meningitis in 1864.  Still devoted his medical 
practice to better understand the human body as current medical practices proved 
insufficient.  He developed an alternative philosophy to medicine centered on the 
musculoskeletal system and its interaction with the other body systems.  He 
conjectured that the body’s structure impacts the function and vice versa.   
Still found that the “musculoskeletal system communicates with the other 
systems through the nervous and circulatory systems”, and conversely, that 
“disorders reach a patient’s awareness through alterations in nervous and circulatory 
system”.  Therefore, nervous and circulatory systems were thought of as the “great 
binders of body unity” (Northup 1979).  Still stated in his autobiography that, “all 
diseases are mere effects, the cause being a partial or complete failure of the nerves 
to properly conduct the fluids of life”.  Therefore, homeostasis could be reestablished 
through precise and direct stimulation of the nervous and circulatory systems.  In 
the 1920’s, professors from the first osteopathic medical school in Kirksville, MO, 
summed up these novel ideas into the four core principles: 
1. The body is a unit; the person a unit of body, mind and spirit. 
2. The body is capable of self-regulation, self-healing, and health 
maintenance. 
3. Structure and function are reciprocally interrelated. 
4- Rational treatment is based on an understanding of the above three 
principles (Gevitz 2004). 
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Somatic Dysfunction 
Somatic dysfunction, once known as osteopathic lesion, meaning “bone out of 
place”, refers to impaired or irregular function of a system, be that skeletal or 
myofascial and their related vascular, lymphatic and visceral elements.  Other 
interrelated systems in the body subsequently respond to this disturbance 
manifesting as pain or degrading function in other areas.  A few examples of the 
interrelated systems response are described by Northup, “rigidity in the muscle over 
the right side of the abdomen when the appendix is inflamed, muscle involuntarily 
contracts and is rigid and painful to the touch, stomach ulcers consistently cause 
areas of spinal irritation just below the shoulders in the back, the radiation of pain to 
the right shoulder from a diseased gall bladder, and reflection of pain and disability 
to the left shoulder following heart disease” (Northup 1979).   
Somatic dysfunction is treated with a variety of manual techniques that target 
the specific type of dysfunction in questions.  Techniques such as articulatory 
treatment (ART), myofascial release techniques, lymphatic pump techniques, or 
Chapman’s reflex points, and respiratory maneuvers, are but a few.  A manual 
treatment is applied with the intention of stimulating autonomic nervous processes 
that ultimately organize efforts to reestablish homeostasis and regain circulation to 
the specified dysfunctional site.  For example, lymphatic pump techniques stimulate 
“nerve centers that control the vasomotor nerves of the blood vessels in the same 
region as the lymph blockage” (Millard 1992).  The clinician may also survey the 
patient during the treatment by asking the subject to rate the pain or tenderness of 
a site being palpated.  Once circulation is restored, nutrients and interstitial fluids are 
also restored to the site and in time, a “release” in the tissue is felt by the DO 
indicating restoration.   
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Other signs of treatment  efficacy include decreased heart rate and 
tenderness.  In chronic patients, OMT efficacy may be transient, and heart rate often 
returns to its elevated state post therapy.  Thus an extended period of therapy 
ranging from weeks to years is required to produce a lasting effect.   
Anatomy and Physiology 
The Nervous System 
The nervous system is composed of the central nervous system (CNS) and 
peripheral nervous systems.  These systems have somatic and autonomic nervous 
divisions.  The somatic nervous system, also called the cerebrospinal nervous 
system, receives input from sensory organs and systems and controls voluntary 
(skeletal) muscles.  The thalamus is the “relay station for the sensory pathways”.  
The autonomic nervous system, or more aptly referred to as the visceral nervous 
system, controls the involuntary muscles, or smooth muscles and glands.  The 
autonomic nervous system regulates unconscious physiologic processes such as 
sweating, blood pressure and heart rate.  The hypothalamus organizes the 
autonomic, endocrine and somatic-motor processes.  Somatosensory and visceral 
organs share neural pathways to transmit information to the CNS (Brodal 2010) 
The present study is concerned with cardiovascular response, which falls 
under ANS regulation.  The autonomic nervous system is further divided into two 
divisions, the sympathetic nervous system (SNS) and the parasympathetic nervous 
system (PNS).  The SNS is concerned with mobilizing the body during situations of 
demand such as stress or emergencies.  The PNS is concerned with daily 
maintenance of the body such as digestion and reproductive behaviors (Brodal 2010) 
(Rhodes 1996).   
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The figure below shows the two branches of the ANS and their respective 
afferent and efferent neural pathways.  Most organs are regulated by both branches.  
The sympathetic chain is lies in the thoracic region, and the parasympathetic nerves 
initiate in the cervical and sacral regions of the spinal column.  
 
Figure 2:  Autonomic Nervous System Branches 
Cardiovascular Innervations 
The heart is innervated by both branches of the ANS.  The vagal nerve is the 
parasympathetic nerve.  Parasympathetic innervations are found only in the 
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sinoatrial (SA) and atrioventricular (AV) nodes of the cardiac muscle.  The 
denervated heart has an increase in heart rate, and therefore the PNS is the 
dominant autonomic function in the heart, which serves to slow heart rate (Rhodes 
1996).  Increased sympathetic activity at the sinoatrial node results in increased 
heart rate.  Increased parasympathetic activity at the SA node results in decreased 
heart rate.  Decreased heart rate allows for more ventricular filling time.  Increased 
stretching of the ventricular wall increases strength of contraction.  Therefore, the 
cardiac output is increased and more blood with greater pressure is output into the 
systemic arteries.  A greater blood pulse wave results in alleviating systemic 
resistance issues (Rhodes 1996) (Hall 2011).   
SNS innervates the endothelial cells which are continuous from the heart and 
throughout the vascular system.  As such, vascular functions are under sympathetic 
control, as distribution of blood is the key function.  The function of larger vessels, 
arteries and segmental arteries, is to transport blood.  As such the vasomotion in 
these vessels are mainly due to blood pressure waves.  The main function of the 
smaller vessels, capillaries and arterioles, is to regulate the distribution of blood flow.  
An increase in sympathetic activity in these blood vessels results in vasodilation 
(Kierszenbaum 2012).  More details are found in the supplemental chapter in the 
appendix.   
Key literature 
Non-evidence based OMT research.  
Numerous non-evidence based clinical studies provided the positive clinical 
outcomes that back these osteopathic philosophies.  For example, Voight et al. 
(2011) demonstrated that the OMT therapy reduced pain and duration of migraine in 
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females.  Other studies have shown reductions in length of hospitalization and 
improvements in symptoms of neonatal infants with use of OMT on gastrointestinal 
function (Pizzolorousso 2011) or pneumonia with use of OMT added to regular 
treatments (Noll 2010).  However, data from these studies are based upon 
subjective feedback to questionnaires and non-qualitative data.  Good evidence-
based research is required to solidify these claims.   
Evidence Based OMT Research 
Invasive Techniques.  Recent evidence based investigations on hematologic 
changes in blood and lymph have been conducted.  Walkowski et al. “investigated 
the effect of OMT on the level of circulating metabolites and leukocytes in healthy 
volunteers” concluding that OMT influenced release of molecules that contribute to 
improved health.  Rivers et al measured albumin, hematocrit, hemoglobin, platelet 
count, total protein, and white blood cell count and systolic and diastolic blood 
pressure at intervals of 20, 50 and 80 min after a 10 minute lymphatic pump 
technique in a group of healthy men.  The results showed statistically significant 
platelet count reduction and increased diastolic pressure at 80min post therapy, 
suggesting sympathoexitetory responses.  However these two studies involved 
invasive methods. 
Cardiovascular responses.  Cardiovascular responses to OMT have been 
previously investigated.  The findings of these studies vary.   Purdy et al. (1996) 
measured digital blood flow (DBF) as a measure of sympathetic activity.   and 
demonstrated that suboccipital dermatomyotomic stimulation (SDS),  placing of 
fingers in the suboccipital region bilaterally and perform slow circular kneading for 
120 seconds, did alter the strain gauge plethysmograph blood flow amplitude and 
the height from dichroitic notch to peak, using 25 healthy subjects.  A touch only 
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protocol, or sham, was found to induce changes in DBF as well, however, to a lesser 
degree compared to OMT.  The study also grouped the subjects by comfort level, and 
found that different groups experienced different degrees of changes.  The group 
reporting comfort during the session had the greatest improvements in DBF.  The 
group reporting most discomfort during the session had a greater response to the 
sham than the OMT.  The report findings suggest that both sham and OMT have 
influences on digital blood flow.  In this study, the analysis was completed on a five 
cycle averaged waveform.  The amplitude was interpreted as “vasomotor tone of the 
dermal vessels”, and the height from dichroitic notch to peak was interpreted as 
“resistance vessel activity, where an “elevation of the dichroitic notch implies a 
relatively vasoconstrictive state, whereas depression suggests vasodilation.   
The study suggested that there were responders and non-responders to OMT 
treatment.  Also from this study it is apparent that subject comfort may be of 
importance in OMT efficacy.  However, one weakness in this study may be the 
dataset length used in analysis.  In a highly variable data set, it is possible that 5 
waveforms may not be representative of the subtle changes that OMT may produce. 
Karason (2001) examined digital blood flow (DBF) with laser Doppler 
flowmeter (LDF) .in 20 healthy males, grouped by smoker and non-smoker, in 
response to sham and high-velocity low-amplitude thrust (HVLAT) to the lumbosacral 
joint.  DBF was monitored in the dorsum of the foot over the L5 dermatome.  This 
study found that the sham treatment produced similar results as no touch.  And that 
the HVLAT produced statistically significant increases in cutaneous blood flow in non-
smokers.  For the purpose of vascular and microvascular research, it is widely 
accepted that smoking negatively effects the compliance of arterial and pulmonary 
vessels.  As such, Tabaco use is nominally included in the exclusion criteria.  So the 
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use of the term asymptomatic in this study may be considered a misnomer.  The 
results from the study also suggest that this may be true.  The aim of the study was 
to “evaluate the short-term effects of a thorough lymphatic treatment protocol and 
designed to include techniques to influence sympathetic tone, the thoracic inlet, the 
thoracic diaphragm, and the lymphatics”, the inclusion of a smoker group would 
serve the purpose of a symptomatic population.  The interesting aspect of this study 
is that the subjects control session occurred a week prior to the active OMT session.  
The duration between rest and OMT is one to be considered.   
Henley et al. (2008) examined a myofascial release technique and its effect 
on heart rate variability. The 17 subjects acted as their own control, and a sham 
procedure was also included in the protocol.  The control, sham and active sessions 
were completed in three separate sessions.  Each subject participated in each type of 
session, to achieve a repeated measures study.  Additionally, a head-tilt was 
employed to induce sympathetic tone.  The time series analysis used 300 seconds of 
continuous data, sampled from the final portion of each phase.  The heart rate 
increased in all three sessions, and the heart rate variability suppression was 
demonstrated during the OMT but not in control or sham.  This served as an 
indicator that the OMT successfully inhibited sympathoexitetory response. 
On the other hand, Milnes et al. (2007) failed to support the theory that C4 
technique lowers sympathetic tone as hypothesized.  In this study a cranial 
technique was applied to C4 in ten healthy subjects.  A sham procedure was also 
used.  In addition to heart rate variability, respiration rate, galvanic skin resistance 
and skin temperature were monitored, yet the heart rate variability proved to be the 
best measure for sympathetic tone.  Only the last five minutes of each phase was 
used in analysis.  The heart rate variability data suggested increases in 
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parasympathetic activity and also provided evidence that there are responders and 
non-responders to the cranial OMT. 
Challenges in OMT Research. 
OMT is often investigated as though it were a drug, and treatment efficacy 
outcomes have shown to be as effective in reducing pain as a drug (Brolinson 2008).  
However, because it is not a drug, and due to complexity and interrelated systems 
and high degree of variability research of osteopathic manipulative treatments face 
challenges in adhering to the scientific method of allopathic medical research.  Early 
et al. (2010) raised some important questions regarding the OMT research fitting the 
scientific research model.  For one, a double blind and controlled studies is difficult to 
achieve logistically.  The reason is simply that clinician cannot be made unaware of 
the treatment that is being applied. 
Another method common to allopathic medical research is the placebo.  In 
OMT research however, the placebo, or sham procedure, has proven to be a 
controversial topic.  In a sham procedure the subject receives a non-therapeutic 
touch or touch only (a standardized sham procedure has not yet been established).  
Skin blood flow has been shown to be responsive even to light touch, gentle 
message or small changes in body temperature (Hisu 2012).  This is especially so if 
the area has been exposed to a manipulative treatment prior to touch as the body 
has the capability of learning and adapting, thereby producing an anticipatory 
response (Early 2010).  For these reasons sham can yield false positive results.   
Another issue arises in standardization in treatment application.  Some 
studies overcome this barrier by monitoring applied pressure at the site of OMT with 
strain gauges.  Others have attempted position tracking techniques.  However, 
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subject to subject variability demands varying application of pressures and symmetry 
of applications to achieve homeostasis (Brolinson 2008).   
In addition to test methodology, measurement methodology is also not 
standardized.  Interpretation of data, for one varies from study to study.  Zeggarra, 
et al. (2014) reviewed hundreds of manual therapy studies in a systematic approach, 
where 20 articles met the criteria.  Their study identified a hand full of techniques 
that are commonly used in OMT research.  Of these many have relative units of 
measure.  Evaluation, therefore, hinges on interpretation of waveform 
characteristics, and mapping that understanding to physiology and clinical outcomes.  
Among the studies surveyed it is evident that the mapping of outcome measures to 
physiologic mechanisms varies and further demonstrates that interpretation of data 
is not a trivial exercise.   
Project Overview 
In consideration of the above, the following approach was taken in this study.  
Central and peripheral vascular changes in response to systemic tests and OMT were 
studied.  This was accomplished in two efforts.  The first effort was a human study 
that used standard photon based sensors operating in the red to infrared wavelength 
regime to measure blood flow in the upper extremities at the arteriole and capillary 
level.  In addition EKG to measure cardiac electrical activity.  In this study an OMT 
protocol on asymptomatic human subjects was followed.  Inclusion criteria were no 
history of cardiovascular disease, and no significant neuro-muscular trauma.  
Tobacco and caffeine use was also prohibited.  Biopac DAQ systems and 
instrumentation, a commercially available product used in medical education and 
research, was used.  As such, this project will hereafter be referred to as the “Biopac 
study”.   
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The second effort was a technique development study.  This study was 
conducted to develop a long-term peripheral vascular data logging capability using a 
sound wave based technology, namely spectral Doppler ultrasound technology.  In 
this study the segmental arteries of the upper and lower extremities were measured 
were monitored during a reactivity test protocol on asymptomatic human subjects.  
No OMT were performed.  This project will hereafter be referred to as the “spectral 
Doppler ultrasound study”.  The matrix below lists the specifications for both studies, 
and the figure to the right identifies the sites of bio data acquisition.  The future 
development of this work is intended to combine the capabilities in these two studies 
to provide a detailed cardiovascular profile.  The chapters 3 and 4 will discuss the 
methods and theory of the Biopac study and the spectral Doppler ultrasound study, 
respectively.  
 
Figure 3: Project Description 
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CHAPTER 3 
METHODS AND THEORY:  BIOPAC STUDY 
The principal investigators of this pilot study were Dr. Deborah Heath and Dr. 
Inder Makin of A.T. Still University, School of Osteopathic Medicine, in Mesa Arizona 
(ATSU SOMA).  This study was IRB approved and consent of the volunteer subjects 
was obtained prior to the experiment.  The IRB approval form is in the appendix.   
The Biopac study non-invasively monitored peripheral flow and electrical 
cardiac activity.  Pulse plethysmography (PPG) and laser Doppler flow (LDF) sensors 
were used to monitor the peripheral vasculature in the upper extremity, at the finger 
tips, bilaterally.  A three-lead EKG was used to monitor the electrical activity of the 
heart.  Room temperature was also monitored throughout each session.  In a 
session, a seasoned clinician administered treatments on a supine subject while a 
separate operator conducted the DAQ and instrumentation.   
Two experimental conditions were examined, a purely baseline session, used 
as a control, and an active session, where OMTs were administered.  In the control 
session the subject lay undisturbed in the supine position for approximately 1 hour.  
In the active session a 15 phase protocol was followed, which included two reactivity 
tests and 5 OMT’s alternating with quiescent phases.  Table 1 shows the sequence of 
events in active session protocol.  The duration of the active session was 
approximately 1.5-2 hours.  36 sessions were recorded in all.  Of these 27 were 
usable for post processing and analysis, where 11 were control sessions. 
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Active Session Protocol. 
The active session has 15 phases including reactivity tests and OMT alternating 
with rest phases.  The table below describes active protocol chronology with phase 
durations. 
 
Table 1:  
Active Session Protocol.   
 
Baseline.  In the baseline phase (~ 12 minutes) the subject is allowed to rest 
come to rest.  No provocations are performed by the clinician.  The subject is 
encouraged not to speak or move unless to adjust for comfort.  In the cases where 
movement did occur, the time was noted and then the noisy data was later parsed 
out. 
Systemic Provocation.  The systemic tests were occlusion and hyperthermia 
wrap of the left arm.  The occlusion was accomplished with an inflatable cuff on the 
upper arm held above 60 mmHg for the duration (3.7  0.3 minutes) of the phase.  
The circulation is should decrease in the occluded arm, while the circulation is 
maintained in the other arm.  Post-occlusive hyperemic reaction was observed (Allen 
2007) (Fullerton 2002) (Bergstrand 2009) (Roustit 2010). 
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The hyperthermia wrap (6.8  1.9 minutes) was accomplished with an 
electrical heated pad wrapped around the upper arm at 38-42 degrees Celsius.  This 
increase in temperature would induce vasodilation in the peripheral vasculature.  
However, during this study the wrap was not consistently effective.   
OMT.  OMT’s used in this study were digital pressure along the vertebral 
column.  The pressure is sustained with minimal tension at the segment until a 
change in tissue texture or temperature was noted.  For this study, five OMTs were 
selected.  These include one maneuver applied to the sternum and four applied to 
the vertebral column as follows:  
Respiratory Maneuver 
OA-C2 
T1-T4 
T8-L2 
L5-S  
Respiratory Maneuver (RM) (0.9  0.3 minutes) was accomplished by applying 
light pressure on the linea alba, located just below the sternum until texture change 
has been noted (Heath 2011).  Data from this phase was noisy, and due to the short 
duration usable data was very limited.  For these reasons the results from this phase 
are not accurate. 
For OA-C2 treatment (5.8  2.4 minutes), pressure was applied to the vagal 
nerve, which runs through a cavity in the spinus process.  The largest space between 
the vertebrae that allows access to the vagal nerve is near the C2 vertebra.  
Pressure along OA-C2 stimulates the vagus nerve inducing a parasympathetic 
excitatory response.  The expected result is a decrease in heart rate. 
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For the T1-T4 treatment (8.4  3.1 minutes) light pressure was applied to the 
vertebral column along the T1 through the T4 digits. The nerves innervated in this 
region include the arms, lungs, heart, and gall bladder. 
For the T8-L2 treatment (5.0  2.3 minutes), light pressure was applied to the 
vertebral column along the T8-L2 digits.  The nerves that innervate these vertebrae 
include the spleen, adrenal glands, kidneys, small intestine and lymph circulation. 
For the L5-S treatment (3.6  1.3 minutes), light pressure was applied to the 
vertebral column along the L5-S digits.  The nerves innervating this region of the 
spinal column include those from the lower legs, ankles, feet, hip bone and buttocks. 
Subject Data 
A total of 20 subjects, 15 female and 5 male, between the ages of 19 and 58 
with a median age of 34 were used in 36 sessions.  Of the 36 sessions recorded 27 
were usable, reducing the sample population to 13 female and maintaining the 5 
male.  A total of 11 control and 16 active sessions with durations of 1±0.2 hours and 
2.1±0.3 hours respectively were included in the final analysis.  Rational for omission 
of sessions is provided in the appendix.  
Subjects were asymptomatic with no prior history of cardiovascular disease 
and no significant neuro-muscular trauma.  Although the subjects selected for study 
were asymptomatic, the clinician identified somatic dysfunction.  These observed 
dysfunctions contributed to the subject-specific responses, where some subject 
displayed an enhanced response, while others had a more subtle response.  A group 
of subjects had an increase in blood flow during OMT, and were subsequently termed 
the peripheral responders.  Another group of subjects had a decrease in heart rate 
during OMT, and were subsequently termed the central responders. 
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Instrumentation, Data Acquisition Setup and Procedure 
Instrumentation and data acquisition 
Biopac is a commercially available data acquisition system primarily used in 
medical education and clinical research applications.  Central and peripheral 
vasculature data were recorded simultaneously using two Biopac data acquisition 
systems.  The PPG and LDF sensors were selected to measure peripheral flow, 
bilaterally.  The PPG and LDF sensors were fixed to the index and middle fingers 
respectively, on both hands.  The PPG and LDF sensors were fastened to the fingers 
with double sided tape and Velcro to maintain sensor placement.  A three-lead EKG 
measured the electrical activity of the heart.  Conducting gel was used on the EKG 
leads to maintain electrode to skin contact and ensure clean signal acquisition.  A 
room temperature sensor was fixed to the table adjacent to the subject.   
Two Biopac units were used for data acquisition.  One Biopac unit had the 
EKG and room temperature electrodes, and was configured as the master box.  The 
second, or slave, Biopac unit had four peripheral flow sensors in the following order:  
Chanel1) left hand PPG, Chanel2) left hand LDF, Chanel 3) right hand PPG, and 
Channel 4) right hand LDF.  With this setup, the operator could manually trigger the 
slave data logger after with the master.  Also, a tagging feature used in the master 
would automatically apply the tag in the slave.  The clinician would inform the 
operator the point in time a new phase began and the operator would manually 
apply a tag in the raw data using a Biopac software function as well as note it in a 
separate tracking sheet.  Two ‘.acq’ data files were produced for each session, one 
file per Biopac box.  The master file contained the EKG and room temperature data 
and the slave file contained the PPG-LDF data.  Tracking sheets were used during the 
session to record in post processing for data parsing.  The tags in the software were 
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not available in the raw data file output.  The EKG and room temperature sensors -
were on the master data acquisition box on Channels 1 and 2, respectively.  The PPG 
and LDF sensors were on a second slave data acquisition box, where Channels 1 and 
3 were PPG left and right side, and Channels 2 and 4 were the LDF left and right 
side, respectively.  The master box was configured to manually trigger the slave box.  
The output ‘.acq’ files were converted to a ‘.mat’ file for post processing in Matlab.  
Room temperature was also monitored throughout the session.  Details on the 
Biopac hardware, instrumentation and software settings are documented in the 
appendix. 
 
EKG Leads
 
Figure 4: Sensor Locations:  on both right and left hand, PPG on index figure, LDF on 
middle finger (left).  EKG Lead placement:  White on right forearm, Black on right 
leg, Red on left leg (right). 
 22 
 
Figure 5:  Biopac DAQ Connection Diagram 
Procedure 
Clinician’s procedure.  The clinician initiated and terminated the session by 
measuring the sitting and resting blood pressure of the subject.  During the “control” 
session the subject lay supine and at rest.  During the active session, the clinician 
followed the active session previously described.  The clinician would ask the subject 
to assess the pain or tenderness at the selected site on a scale from 0 to 3, 0 being 
no tenderness.  The clinician’s aim was to reduce the rating to zero with treatment.  
These pain ratings were recorded both pre and post therapy.  The clinician also noted 
the level of effort required for reducing pain rating.  The clinician used these indices 
to later assess and classify those subjects with most improvement as clinical 
responders. 
Operator’s Procedure.  A separate operator managed the instrumentation 
and data acquisition and, subject comfort.  The sensors were calibrated, and gains 
adjusted per session.  The available options for gain settings in the version of Biopac 
used were the default 5000 and 2000.  The master box acquisitioning was initiated 
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and when the clinician was ready to start the procedure.  When the master data 
settled to a clean signal, the operator hit a manual trigger on the master GUI to 
initiate the slave box acquisition.  Adjustments were made to the sensor position and 
fastening and subject position on table to ensure optimal signal acquisition.  The 
procedure could begin when clean signals were noted. 
The operator noted change of phase using a tagging feature on the software 
as well as recorded the time on a separate tracking sheet.  The tracking sheet was 
also used to record the blood pressures, room temperatures and any other notes 
throughout the session.  At the end of the session, the data logs were saved and the 
subject was allowed to sit up.   
Sources of Variability 
Data contained a large amount of variability.  For one, the vasculature of 
human subjects presents a large degree of variability, both from subject to subject 
as well as within one subject from day to day, minute to minute.  Changes in blood 
flow and cardiac rhythms stem from physiologic adaptations to external 
environments such as room temperature and altitude change, to internal 
environments such as mental state or disease.  These factors drive autonomic 
processes, heart rate variability, and metabolic changes.  These changes can be 
observed in biophysical signals.  
Room temperature during the study was source of variability.  The room 
temperature within the room where the sessions took place fluctuated within 3 to 4 
degrees Celsius.  This could have an effect on the peripheral vasculature as it adapts 
to temperature changes, therefore the measurements will express this variability.  
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Sensor positioning and fastening were another source of variability.  If the 
PPG or LDF sensor was fastened too loose on the finger the detected signal would be 
weak.  Also, a loose contact between the sensor and finger might introduce other 
light artifacts.  If the sensor was fastened too tight on the finger the vessels would 
be compressed, and the signal output would be distorted and noisy.  During one 
session, the subjects hands were face down, such that the table added pressure on 
the sensor and finger.  The signal was not usable and the session data was omitted 
from analysis.  Thereafter, the position of the hands was standardized to be palm up, 
and the fastenings of the sensors were adjusted until maximum signals were 
obtained.  Sensor position was not changed during the session, unless the sensor 
was displaced.  
The duration of the OMT was another variable.  Early on in the program, the 
sessions had shorter duration OMTs.  The resulting raw data had a similar result as 
the control sessions, showing a decaying trend.  Subsequently, the clinician 
increased the duration and intensity of the treatment to increase the effect of OMT.  
These sessions were termed “long duration” sessions.  The short duration sessions 
were excluded from final analysis.   
The duration of the manipulations during the long duration sessions was also 
variable OMT application is subject specific.  The standardization factor in this study 
was the subject feedback of tenderness rating (0-no tenderness, to 3-maximum 
tenderness) before and after treatment.  Subject perception of tenderness is 
subjective and not quantitative.   
Subject comfort was suggested by Purdy et al. (1996) as a variable in OMT 
efficacy.  During the control sessions the subject discomfort and movement was 
minimal, but during the active sessions the subject tended to readjust for comfort 
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more as a result of the interaction with the clinician.  A blanket was provided per 
subject request.  Pillows for under the head and knees were also provided to assist in 
a more relaxed posture.  Because the table was narrow, arm rests used to ensure a 
relaxed position of arms naturally and slightly away from the body, without the arms 
falling off of the table.  Without the boards the subject would need to expend effort 
holding the arms close to the body.  Even this amount of effort from the subject 
could lead to distortion and possible false positives.  It is important that the subject 
is made comfortable prior to beginning any readings, as any major postural changes 
would result in increased circulation.  Subject 26 is an example of this.  Towards the 
end of the session the subject requested a pillow for the under the knees which 
resulted in increased blood flow in the upper extremities as well as changes in heart 
rate.  This portion of the session had to be parsed out from the processed data.   
The subjects’ state of mind, i.e. stress and anxiety levels, is another source of 
variability which was not accounted for.  The state of mind of the subject may 
influence autonomic processes that regulate blood distribution (Bordal 2010).  This 
variable was not monitored, measured or controlled. 
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Validation of Raw Data 
Pulsatile Waveform 
The raw data from the PPG, LDF and EKG signals were validated.  The blood 
flow waveforms are pulsatile in nature based upon cardiac activity and vasomotion, 
displaying systolic and diastolic peaks and dichroitic notch (Allen 2007) (Bergstrand 
2009) (Chu 2009) (Nitzan 1998).  The raw data from the PPG and LDF signals 
displayed this characteristic.  Figure 6 below is an excerpt of the raw data from 
Biopac, PPG (trace 1 and 3) and LDF (trace 2 and 4), of the session with Subject 5.  
The waveform from both sensors have the pulsatile nature of the cardiac rhythm, 
and furthermore shows a slow wave, or varying low frequency baseline that may be 
attributed to respiration, sympathetic nervous system activity and thermal regulation 
(Allen 2007).  
 
Figure 6:  Peripheral Flow Raw Data:  blood flow data from Biopac DAQ of Subject 
17 session shows pulsatile behavior of volume (PPG) and flow (LDF) signals, as seen 
in the cardiac pulse.  The slow wave in LDF signal is due to a DC shift caused by 
variations in sinoatrial node depolarization.  The PPG signal does not have this slow 
wave due to a high pass filter in the software.   
Post-Occlusive Reactive Hyperemia. 
A post occlusive reactive hyperemic response was seen in all of the subjects.  
During occlusion the blood flow signals flatten out, indicating reduced flow and blood 
volume.  During this time of zero blood flow, metabolic waste builds up in the tissue 
including vasodilators, which decreases systemic resistance.  After the pressure in 
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the cuff is released there is a transient surge of blood flow due to lowered systemic 
resistance (Rhodes 1996).  At the same time there was an observed decrease in flow 
in the right hand, indicating regulatory mechanisms maintaining equilibrium in 
systemic circulation.  The figure below shows the release of occlusion the left arm 
followed by a reactive hyperemic response, shown by an immediate increase in 
signals.  This agrees with literature suggesting an appropriate systemic response of 
the subject as well as data acquisition system (Freccero 2003) (Eun 1995) (Knotzer 
2007). 
 
Figure 7: Post-Occlusive Reactive Hyperemia 
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Bilateral measurements 
In this study bilateral measurements were taken from the upper extremities.   
During occlusive and hyperthermia wrap of the left arm phases we were able to 
verify that the data acquisition system was operating appropriately.  Bilateral 
differences observed in the peripheral blood signals are agree with literature, Allen 
(2007),  Asymmetry of the body is well documented in literature, for example, 
metabolism of dominant arm during drug uptake and corresponding contralateral 
side of  the brain (Simonsen 2008) (Korf 1980), neurochemical  bilateralism, nerve 
innervation, and cerebral bilaterality, and local vascular and lymphatic circulation 
asymmetries.  Bilateral measurements are clinically significant in diagnosing 
peripheral vascular occlusive disorders (PVOD), (Chang 2001). 
The sensors were switched to the opposite hands to ensure that no bias was 
present.  Subjects 05 and 16 are examples of sessions where the sensors were 
switched.  The data shows that in swapped and non-swapped sessions the right hand 
data had greater magnitudes than the left hand.  The system test for this validation 
effort is found in the appendix. 
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Posture change 
Another observation that validated the raw data was the increase in upper 
extremity blood flow after the legs were elevated.  A lower extremity posture change 
should lead to a decreased peripheral flow the lower extremities. This results in 
upper extremity blood flow increase to maintain balanced systemic pressure.  To 
facilitate the investigation of the reflex responses, a change in posture is regarded as 
one of the commonly used convenient tests (Foo 2009).  In the Figure 5 subject 26 
changed the posture of the lower extremities resulting in an increased peripheral 
blood volume and flow to the upper extremities, both right and left side.   
 
Figure 8:  Posture Change.  Subject 26 blood flow increased in upper extremity due 
at 58min when supine subject raised legs and placed a pillow under knees for 
support and added comfort.   
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Simulation 
Simulation of the PPG and LDF blood flow waveforms in Matlab were 
completed in order to better understand the components of the signals.  Three 
sinusoids were summed to simulate the signals: 
Figure 9  shows the results of the PPG and LDF simulation.  The top plot shows the 
simple summation of three sinusoids to obtain the PPG and LDF waveforms.  The PPG 
signal had a high pass filter (HPF) at 0.5 Hz.  As such the DC shift and slow wave 
components were absent for the waveform.  The LDF signal did have these 
components.  This simulation is shown in the Figure 9 (a).  Figure 9 (b) and (c) 
shows the PPG and LDF waveforms, respectively, with added random noise.  The 
resultant power spectral density estimation (PSD) is shown below the simulated 
noisy waveform.  These figures are compared to the raw data waveforms and their 
respective PSD estimation on the right.  In the PPG signal the peaks at 1 and 2 Hz 
are seen.  In the LDF signal the peaks a DC component and peaks at 0.1, 1 and 2 Hz 
are seen. 
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(a) 
 
 
(b) 
 
 
(c) 
 
Figure 9:  PPG and LDF simulation 
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Pulse Plethysmograph 
Sensor Introduction and Applications 
The plethysmography technology has been in use in the medical field for over 
80 years. The PPG is a non-invasive sensor that is attached to a thin area of the 
body such as the ear, fingertip or toe to measure skin blood flow.   
Because it is customizable to many applications, the PPG sensor is used to 
monitor a variety of biophysical signals.  Applications range from monitoring air 
volume in lungs, to blood flow in organs such as kidneys, genitals, and cerebrum, 
and oxygen saturation of blood.  Anything that may affect peripheral blood flow can 
be monitored by the PPG sensor.  Respiration, for example, can be monitored.  Since 
respiration acts as a cardiac pump, a decrease in respiratory rate results in a 
decrease in cardiac volume, leading to a decrease in peripheral flow.   
The PPG sensor is also used during surgery to monitor anesthesia depth.  If a 
patient has a response to an incision the PPG will shows as an increase in amplitude 
indicating sympathetic response to the pain.  A pulse oximeter monitors the oxygen 
saturation in blood at the fingertip by using a specific wavelength that is absorbed by 
hemoglobin, a protein that carries oxygen in blood (Shelley 2007).  The features on 
a PPG waveform can be used in diagnostics.  A study in 1940 compared the crest 
time from the peak of a PPG waveform normalized to the heart rate with normal and 
hypertensive subjects.  The hypertensive subjects showed an increase in crest time 
(Allen 2007) (Foo 2009).  Recent interests have turned to using the PPG to monitor 
sympathetic activity via hemodynamic responses.  Sleep apnea causes sympathetic 
vasoconstriction responses which increase blood pressure during sleep.  The PPG 
waveforms are used to assess ANS reflex response (Foo 2009).   
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The advantage of using the PPG sensor is that it is versatile, low cost, non-
invasive and is suitable for long-term measurements.  The photo pulse 
plethysmograph used in this study measures blood volume changes in the 
microvascular bed.   
PPG Sensor Operation 
The PPG sensor is composed of photo emitter and a photo detector.  It uses 
infrared light to illuminate the skin and the detector to catch the reflected light off of 
the blood vessel wall.  Depending on the application, a specified wavelength, within 
the red and near infrared light range is used.  The wavelength of the light emitted is 
generally between 600 and 700, or the near red region because skin pigments, 
oxyhemoglobin, hemoglobin and bilirubin minimally absorb the light, and optical 
density of skin due to erythema is negligible (Kamal 1989).  Green light at around 
800 nm has been used to reduce the penetration depth (Bergstrand 2009).   
Because there is no calibration procedure available to standardize the PPG 
voltage reading between subjects the signal can only have a relative unit, where “the 
value of the plethysmography comes from an analysis over time, as opposed to an 
absolute number” (Shelley 2007).  As such sensor provides a signal where the 
absolute value is not known (Kamal 1989) (Shelley 2007).    
 
(1) 
 
 
Figure 10:  PPG diagram and equations 
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Penetration Depth.  Light is absorbed by water, the major component of the 
tissue, and transmitted, reflected, and back scattered by the vascular structures in 
the finger pulp Bergstrand et al demonstrated that the penetration depth of the PPG 
light source depends upon the wavelength of the light source and the distance 
between the light source and the photo detector (Bergstrand 2009) (Allen 2007).  A 
green light wave length of 560 nm will provide a measurement depth of 2 mm with a 
5 mm distance from the photo detector, and a near-infra red light at 810 nm can 
provide a deeper measurement depth at approximately 8 to 20 mm with a distance 
of 5 and 10 mm from the photo detector respectively (Bergstrand 2009).  Roberts 
reports of a study conducted in 1979 by Challenor “who compared outputs operating 
at 805 and 650 nm and found their outputs to be substantially the same” (Roberts 
1982).  Per the Biopac documentation, the PPG sensor TSD200 measures changes in 
the blood volume in the capillary bed. 
Configurations.  There are two main configurations, the transmitted and 
reflectance PPG sensor.  In the transmitted configuration the finger is placed 
between the emitter and detector and the light transmitted through the tissue is 
detected.  The transmitted light is measured so that the peak light transmitted is at 
diastole when blood volume is low.  The resulting signal is usually inverted so that 
systole is the peak, and diastole is the minimum.  In the reflectance configuration 
the emitter and detector are adjacent and placed on the same side of the finger.  
The reflected, or back scattered, light is detected.  The resulting signal shows the 
systolic peak as the maximum intensity and diastole is the minimum intensity.  The 
PPG sensor would also detect prominent levels of venous return (Shelley 2007) 
(Nitzan1989) (Kamal)  Pulse pressure is attenuated as it propagate from the heart to 
the systemic vessels.  But the cardiac rhythms due to heart rate and heart rate 
variability are present in the flow and are captured in the PPG signal.  Roberts states 
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that transmitted PPG sensors contain more artifacts due to sensor detector and 
emitter alignment and fastening, and increased artifact light sources detected.  This 
project uses a reflectance PPG.   
Waveform.  Steady blood flow appears as a constant volume.  When blood 
pulses through the arteriole and capillary beds, the vessels dilate and tissue blood 
volume increases and the intensity of reflected light increases (Allen 2007) (Nitzan 
1998).  Similarly, when the pulse diminishes the vessel constricts and there is less 
tissue blood volume, and more light is absorbed into the tissue back, resulting in a 
decreased reflected light intensity.  The light intensity is then converted to a voltage.  
Nijboer et al. (1981) found that the relationship between light intensity detected and 
voltage produced by it are not linear.  They also reported that the light emitted by 
the reflectance sensor was stronger compared to the transmittance.   
 
Figure 11:  PPG sensor Light intensity vs. voltage relationship (Nijboer 1981) 
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PPG Raw Data and Time Characterization. 
The PPG waveform represents the cardiac cycle showing systole, diastole and 
dichroitic notch.  In a compliant vessel, pulsing waves of blood distend the vessel 
walls.  The endothelial cells lining the vessel walls also respond to this stretching.  
When a vessel wall is stretched, the endothelial cells also stretch causing increased 
depolarization.  As the membrane rate of depolarization increases, the amount of 
constriction increases.  This response to vessel wall stretching is also known as 
myogenic activity (Rhodes 1996).   Autonomic activity also regulates vasomotion, by 
shunting capillary vessels diverting blood to and from neighboring tissues and organs 
upon demand.  The PPG sensor measures these changes in vessel wall distention.   
The PPG waveform has an AC component and a DC component (Kamal 1989).  
These components are caused by the cardiac pulse pressure and changes vascular 
resistance (Allen 2007).  The DC component represents the non-pulsing arterial 
blood and venous blood, and the AC component represents the pulsing arterial flow 
(Abdollahi, 2013).  The DC component therefore represents the resting tone of the 
vessel wall, and the AC component represents the changes in vessel diameter due to 
pulsing fluid.   
The PPG waveform is often used as a measure of blood volume based upon 
the rational that as the amount of blood in the tissue increases PPG signal increases.  
However, in this project, the PPG waveform only shows the AC component, the pulse 
pressure changes.  The DC component, or the mean value (MV), was removed by the 
high pass filter (HPR) in the software.  As such, the PPG signal does not provide a 
complete measure of blood volume.  To have an increase in blood volume over time, 
both area and blood velocity must increase.   
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Figure 12:  PPG waveform from the Biopac DAQ 
The signal strength varies from subject to subject mainly due to varying 
physiologies; as such the gain was adjusted in the software per subject to produce a 
yield an optimal signal without clipping or data loss.  A high pass filter was applied in 
the software at approximately 0.5 Hz.  Due to the high pass filter the DC component 
was filtered out and waveform shows as distributed about an approximate zero 
mean. Vasomotion, provide by AC and DC components, are the low frequency 
components in the spectral domain, and are mediated by sympathetic activity 
(Nitzan 1998) (Allen 2007) (Shelley 2007) (Kamal 1989) (Foo 2009).  Low frequency 
range is 0.04-0.4 Hz and higher frequency ranges from 0.5-2Hz.  The period of the 
PPG signal represents the cardiac cycle and is used as a measure of heart rate 
(Nitzan 1998) (Allen 2007).  The PPG waveform was characterized with three 
estimators.  These were the peak-to-peak value (PP) or AC component, the root 
mean square (RMS) value providing the average diameter over a cardiac pulse, and 
the mean value (MV) or DC component, which was approximately zero due validating 
the effect of the HPF. 
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Laser Doppler Flowmeter 
LDF Introduction and Applications 
The LDF sensor is a non-invasive fiber optic sensor that measures blood flow 
over time.  The LDF sensor emerged in early 1970’s, and was first used to measure 
blood flow of retinal vessels in rabbits.  Shortly after its use was extended to human 
skin blood flow (EUN 1995) (Humeau 2010).  Because of its low cost, non-invasive 
method of monitoring microvascular blood flow the LDF sensor is used in many fields 
and applications.  It is used extensively in the field of dermatology for determining 
pathologies of the microvessels such as diabetes or Raynaud’s phenomenon, to 
pharmacological research measuring effects of vasodilators (Eun 1995)(Humeau 
2010).  It is also used in therapeutic applications such as diabetes therapy, plastic 
surgery.  It is also used in many tissues aside from epidermis, such as studying 
ischemia in brain, liver and kidney tissues (Bergstrand 2009) (Fredriksson 2009).  
Esen et al. describes how the LDF output is also used for examining responsiveness 
of blood flow control mechanisms to understand endothelial function and 
dysfunction, for vascular disease diagnosis and prediction (Esen 2009).  The sensor 
can be placed on the ear, forearm, finger and toe, each providing a slightly different 
waveform. (Roustit 2010) (Allen 2007).  In this project, the LDF measurements are 
taken from the middle fingers of the right and left hand.   
LDF Sensor Operation 
The laser Doppler flow meter is comprised of a helium-neon light source and 
two fiber optic cables, one that delivers light, and one that detects light, measuring 
cutaneous blood flow (Eun 1995) (Fredricksson 2009)(Kvernmo 1999).  A signal 
conditioner is connected to the sensor band pass filtering the signal prior to output.  
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For the moor instruments LDF sensor the cut off angular frequencies are generally 20 
Hz to 3-22 KHz depending on the laser wavelength and blood cell speeds (Moor 
Instruments).  The LDF sensor uses a specific wavelength of light to illuminate the 
skin, and detect the change in the wavelength reflected back to determine changes 
in blood flow.  Compared to the PPG sensor where the vasomotion contributes to the 
signal output, the LDF sensor output is yielded from the blood cells movement only 
(Fredriksson 2009).   
The LDF sensor uses the Doppler shift of the red blood cells to determine 
velocity of blood in the capillary bed.  LDF provides a measurement of blood flow by 
detecting the first power spectral moment of the reflected light containing the 
Doppler-shifted content.  The backscattered light detected by the photodiode is 
amplified and processed resulting in an analog output signal in millivolts [mV].  The 
output, however, is expressed as relative unit called blood perfusion unit [BPU], 
where 1 BPU is a “pre-defined electrical signal in mV” (Knotzer 2007). The LDF 
output plots the Doppler shift as a perfusion measurement.  This shift is 
mathematically a change in position over time, which gives a measure of velocity.  
The greater the velocity of the RBC the greater the Doppler shift, therefore showing 
an increased signal.   
 
(2) 
 
 
 
Figure 13:  LDF Diagram and Equations 
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Penetration Depth.  The penetration depth is dependent on the optical 
properties of the tissue and the probe geometry (Fullerton 2002).  From subject to 
subject, the vasculature within the sampling volume varies in “size, function, 
tension, tonicity and microanatomical orientation relative to the incident and 
reflected laser light” (Fullerton 2002), and the skin varies in thickness and 
pigmentation (Freccero 2003) and effect the interaction with the light.   Light 
wavelengths of the LDF probe range from green light to near infrared light, 540nm to 
780nm, and shallow to deep, respectively (Fredriksson 2009), where near infrared 
lights are found more prevalently in modern LDF sensors.  With the above factors 
considered, the sample size depth can range from 0.25-1.5 mm, where the blood 
flow values represent the flow in the capillaries and smaller vessels (Fullerton 2002) 
(Fredricksson 2009) (Knotzer 2007). 
Configurations:  The LDF is used as a fiber optic device.  A modification of 
the LDF sensor is found in scanners, or perfusion imagers (Bergstrand 2009), where 
the moving mirrors are used in place of fiber optics (Eun 1995), creating a two 
dimensional flow map (Fullerton 2002). 
Waveform.  Steady blood flow appears as a constant velocity.  When blood 
pulses through the arteriole and capillary beds the red blood cells (RBC) accelerate.  
The detected shifted frequency of the RBC therefore increases.  Similarly, when the 
pulse diminishes the RBC decelerates, the shift is smaller and the light intensity 
decreases.  The light intensity is converted to a voltage output.  The voltage is 
related to velocity using the Doppler shift equation. 
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LDF raw data and time characterization 
The LDF waveform shows the pulsatile cardiac cycle as the change in RBC 
velocity over time.  In a vessel with non-compliant walls, the change in blood 
velocity would be due to blood pressure from ventricular contractions.  An increase in 
heart rate would allow less time for ventricular filling and therefore require a weaker 
ventricular contraction would eject that smaller amount of blood into the systemic 
arteries.  A decreased heart rate would allow more time for ventricular filling and 
produce a stronger contraction in order to eject the greater amount of fluid into the 
systemic arteries.  The resulting blood pressures would cause a wave to propagate 
through the vessels, thus altering the RBC velocity.  The RBC velocity is also 
influenced by the frictional resistance between the RBC and vessel wall.  As the wall 
constricts friction increases causing the blood flow to slow.  A dilated vessel would 
decrease resistance by increase the cross-sectional area for blood to flow freely.  The 
LDF signal provides a measure of the changes in RBC velocity over time. 
The LDF waveform has an AC component and a DC component.  The AC 
component is the amplitude of the wave, measured as a PP value.  The DC 
component is the shift above zero mean, measured as a MV.  The average value of a 
pulsatile signal can best be determined by the RMS value.   The LDF RMS measure 
provides average velocity of the RBC.  The PP, MV and RMS values were measured 
for each cardiac cycle.   
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Figure 14:  LDF Waveform from Biopac DAQ 
Frequency Components of PPG and LDF Signals 
The dc component relates to the gross amount of blood pooling in the tissue 
(Kamal 1989).  The ac components of the signals are from 0.01-6Hz.Sympathetic 
activity is related to components from 0.01-0.5 Hz.  Murthy et. al. (2001) describes 
spectral analysis techniques which identify atrial flutter as components at 0.6 and 
0.8 Hz corresponding to two and three flutter waves.  Post MI subjects showed 
frequencies between 0.2 and 0.3 Hz corresponding to loss of “sympathetic pacing of 
the heart”.  Lower frequency components, below 0.1 Hz of the PPG signal correspond 
to physiologic activity:  myogenic, neurogenic and endothelial, related metabolic 
activities correspond to intervals 0.052–0.145 Hz, 0.021–0.052 Hz, 0.0095–0.021 Hz 
respectively (Humeau 2004) (Bracic 1999).  These low frequency spectra were not 
analyzed in this project   
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The modulated heart rate is found between 0.5-2Hz.  A normal heart rate is 
between 55-70 BPM, corresponding to peaks at 0.9-1.17 Hz, respectively (Murthy 
2001) (Humeau 2004) (Kamal 1989).  The heart rate is modulated by the 
sympathetic components found below 0.5 Hz.  The sidebands found around the heart 
rate, or carrier frequency, occur as those below 0.5 Hz.  The amplitude modulation of 
the heart rate is due to variation in systemic resistance.  The frequency modulation 
of the heart rate is due to the variation in sympathetic activity in the myocardium, 
due to vagal response or respiration, for example.  A Traub-Hering-Mayer (THM) 
frequency produced by the ANS at 0.1 Hz is produced both at the SA node and by 
the vascular tree to push blood through.  The SA node 0.1 Hz component is due to 
parasympathetic activity, and FM modulates the HR.  The vasculature 0.1Hz 
component is produced by sympathetic activity and AM modulates the HR.  This is 
seen in the time wave as a dichroitic notch.  An amplitude modulated carrier 
frequency has a spectrum with a large carrier frequency and lower magnitude 
sidebands.  A frequency modulated carrier frequency has a greater magnitude 
sidebands, and lower magnitude carrier frequency.  Similarly, heart rate variability 
(HRV) is inversely related to heart rate.  The HRV is a result of SA node activity.  The 
HRV therefore FM modulates the HR.  When HRV increases, HR decreases. And if HR 
increases, HRV decreases.  HRV is more and more being used as indicator of 
cardiovascular health.  Decreases in HRV predict mortality following myocardial 
infarction.  Changes in HRV are found in diseases ranging from congestive heart 
failure to diabetes to depression (Heitmann 2011). 
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Higher frequency components, greater than 2 Hz correspond to harmonics 
(Kamal 1989).  Kamal et. al. describes the fate of the harmonics from heart to 
capillary bed.  In the aorta harmonic components spread up to the up to the 20th 
harmonic.  Blood pressure and flow attenuate as blood travels away from the heart.  
The number of harmonics increases as blood flows away from the heart.  The higher 
harmonics, above 3 Hz, are attenuated by the precapillary sphincter.  At the site of 
the PPG sensor, the fundamental was attenuated, the harmonics were amplified, and 
the higher harmonics were filtered.  The harmonics do not have a clinical 
significance.   
Electrocardiography 
EKG Introduction and applications 
Electrocardiography (ECG or EKG for the German term elektrokardiogramm), 
is a non-invasive method of measuring electrical activity of the heart.  The electrical 
activity from a depolarizing cardiac muscle is a dominant and pervasive signal that 
can be detected in many ways, including as electrical activity on the skin.  Three 
electrodes, a positive, negative and ground, placed on an area of the body will detect 
the electrical activity central to that site.  When the three leads are placed on the 
extremities of the body the central activity that is detected is the sinoatrial 
depolarization.   
A twelve lead EKG is used in clinical diagnostics.  The three-lead EKG is not 
useful for diagnostic purposes, but was sufficient for the purpose of this study, which 
was to obtain heart rate and heart rate variability.   
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EKG Raw Data and Time Characterization 
The raw EKG data clearly shows the QRS complex, describing electrical 
depolarization and repolarization of ventricles.  The greatest electrical activity occurs 
at ventricle depolarization (between R and S), where contraction of muscle ejects 
blood into the systemic arteries.  The interval between subsequent R waves, called 
the inter-beat interval or RR interval, was used to calculate heart rate: 
𝐻𝑅 =
60
𝑅𝑅
=
𝑠𝑒𝑐∗𝑚𝑖𝑛−1
sec∗𝑏𝑒𝑎𝑡−1
=
𝑏𝑒𝑎𝑡
𝑚𝑖𝑛
= [𝑏𝑝𝑚]    (3) 
 
Figure 15:  EKG output from Biopac DAQ 
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Post Processing 
Data Parsing 
   One hundred seconds of clean data were parsed out from each phase.  
Ideally the data was taken in ten second sections evenly spread throughout the 
phase.  The data was processed in ten second patches at a time.   
 
Figure 16: Data Parsed from PPG and LDF data. 
Time Domain Analysis 
PPG and LDF.  For the PPG and LDF data each cardiac cycle was isolated and 
characterized individually.  A peak detector was developed to isolate each cardiac 
cycle.  The peak detector was customized for each subject based upon their resting 
heart rate.  The peaks were used to identify an average time step, or heart rate, 
within the ten second patch of data.  The data was stepped through using this 
calculated average cycle time.  The time characteristics were calculated for each 
cardiac cycle.  The mean estimator was calculated for each phase.  And a cumulative 
estimator was calculated with all trials. 
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Figure 17:  PPG and LDF Peak to Peak Detector output for LtLDF signal at two 
different 10 second segments in Subject 07 Quiescent phase 2 
EKG.  A peak detector was also created for the EKG data as well.  Heart rate 
was calculated from the interbeat interval.  The mean was calculated for each phase.  
And a cumulative mean was calculated with all trials. 
 
Figure 18: EKG Peak detector output for Subject 07 Quiescent phase 2 
Volume Flow.  The concept of volume flow is used in fields varying from 
medical to industrial, in order to determine flow through a tube, or vessel.  Abdollahi, 
et. al proposed a novel method of combining the PPG and LDF sensors into a single 
unit in effort to “indicate the presence and magnitude of blood flow”.  This technique 
was developed for the purpose of providing an early warning of ischemia during 
bowel surgery.  In their study the sensors were adjoined to obtain readings from the 
same site simultaneously.  The waveforms were output as two separate data sets. 
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In this project, volume is also valuable. The flow may not necessarily be 
improved if only vessel diameter increases or only blood flow increases.  Velocity of 
fluid slows through a widening pipe, and increases through a narrowing pipe, but 
flow in either case is conserved due to continuity and conservation of mass.  To 
obtain improved peripheral flow both measures must increase.  The following is 
proposed to identify increase in velocity coincident with increase in vessel cross 
sectional area to serve as an indicator of peripheral flow enhancement.   
It was not feasible to adjoin the two peripheral sensors in the same finger due 
to sensor size and positioning/fastening requirements.  Instead, a numerical 
representation of the presence and magnitude of flow was proposed.  This was 
obtained by taking the dot product of the PPG and LDF signals.  The rational for this 
mathematical representation is as follows.  The PPG signal provides measure of 
vessel diameter, or an area (𝐴 = 𝜋𝑟2) of the vessel, and the LDF signal provides the 
velocity of the RBC within the vessel.  The volume can then be found by multiplying 
the area times the volume.  Blood flow is defined by the volume of blood over per 
unit area per unit time (Rhodes 1996).   
𝑽𝒐𝒍𝒖𝒎𝒆
𝑻𝒊𝒎𝒆
= 𝑨𝒓𝒆𝒂 ∗ 𝒗𝒆𝒍𝒐𝒄𝒊𝒕𝒚     (4) 
The figure below shows the PPG and LDF waveforms from both hands and 
their resultant volume.  At the 10 second mark and the 47 second mark we can see 
that the volume-flow increasing and decreasing, respectively.   
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Figure 19:  Volume-Flow.   PPG, LDF (Left) and Volume (right) waveforms. of excerpt 
from Subject 17. 
From this plot we can observe that that the PPG PP and LDF MV contribute to 
the volume.  An increase in velocity, seen as LDF MV, occurs with decrease in 
vascular resistance, seen as increase in PPG PP.  The figures above show an increase 
(or decrease) in the LDF MV and the PPG PP on the left and corresponding increase 
(or decrease) in the volume on the right.  The LDF PP, or ventricular contraction, 
does not show any dominant effects on the volume PP.  The PPG MV has the effect of 
a HPF, so that the LDF MV only modulates the PPG amplitude.  Nevertheless, we can 
see enhanced volume from 0 to 20 seconds, and diminished volume from 40 to 50 
seconds.  Also we can note that the volume in the right hand has greater amplitudes 
than the left hand. The volumes for right and left hand were calculated and 
characterized in with the same manner as the PPG and LDF waveforms, with PP, RMS 
and MV.   
The limitation of this method is that the two data sets are from different 
vessels (different fingers and different depths of the skin).  Also, the high-pass filter 
on the PPG signal also limits the output.  If the slow wave component were available, 
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volume MV calculation could provide a representation of volume when the heart is 
not depolarizing, or at rest.  This volume calculation with the addition of the PPG 
slow wave component could merit further examination in future work. 
The table below provides a summary of the time domain characterizations 
and interpretations.   
Table 2 
Summary of Blood Flow Outcome Measures 
 
Frequency Domain Analysis 
PPG and LDF.  The same 100 seconds of data parsed for the time domain 
calculations were contacted into one data set per phase.  The data set was multiplied 
by a hanning window function. The power was calculated to yield the power 
spectrum.  The first 5Hz of data were reviewed.  After this point the spectral content 
decays. 
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Figure 20:  Non-normalized PSD of LtPPG:  Subject 11 Quiescent Phase 3 
Normalization Approach.  For each subject a normalization factor was 
calculated by taking the peak heart rate of the entire session.  In this way the 
change in spectral content throughout the session can be observed in relation to that 
peak.  For the LDF signal, the peak occurs in the DC component of the signal.  The 
algorithm to find the peak was altered for the LDF signal to only detect the peak at 
the heart rate, and ignore the peak from the DC component.  
The PSD data assembled in a Matlab image, with phases in the x-axis and 
frequency in the y-axis.  The color scale provides the normalized magnitude of the 
signal.  See figure below. 
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Figure 21:  PSD Estimate Image:  Subject 07 LtLDF. 
Hsiu et al. (2012) suggested that harmonics can be used to quantify 
microcirculatory responses and provide information on pulse transmission of 
frequency components.  The frequency spectrum either bandwidth either increases 
or decreases during a phase.  To spectral broadening was quantified.  First the 
spectrum was split into three ranges of interest: 
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Table 3 
Frequency Components of PPG, LDF and EKG Signals 
Component PPG LDF EKG 
Slow wave  
(0-0.5 Hz) 
sympathetic 
activity that 
modulates heart 
rate(0.01-0.5 HZ): 
-endothelial activity 
(0.0095-0.021 Hz),  
-neurogenic activity 
(0.021-0.052 Hz),  
-myogenic activity 
(0.052-0.145 Hz), 
- respiration  
(0.03 Hz), 
- THM frequency to 
pulse blood in both 
SA node and 
vasculature (0.1 HZ), 
(Humeau 2004, 
Kamal 1989, Murthy 
2001) 
sympathetic activity 
that modulates heart 
rate(0.01-0.5 HZ): 
- respiration (0.3 Hz),  
-myogenic activity, 
blood pressure 
regulation  
(0.10; 0.06-0.2 Hz),  
-neurogenic 
activity(0.04 Hz),  
-vascular endothelium, 
metabolic activity—the 
rhythmic regulation of 
vessel resistance to the 
blood flow initiated by 
concentrations of 
metabolic substances 
in the blood (0.01 Hz), 
(Bracic 1998, Rossi 
2008) 
Low frequency 
due to 
sympathetic 
activity (0.04-
0.15 Hz) 
High frequency 
due to 
parasympathet
ic activity 
(0.15-0.4 Hz). 
LF/HF ratio 
provides the 
heart rate 
variability 
(HRV) 
(Henley 
2008)(Lewis 
2005)(Delaney 
2001) 
Fundamental 
(0.5-1.5 Hz) 
heart rate (Humeau 
2004, Kamal 1989, 
Murthy 2001) 
heart rate(Bracic 
1998, Rossi 2008) 
Heart rate 
(Kilpatrick 1994) 
Harmonics 
(1.5-3 Hz) 
Blood pressure 
waveform directly 
proportional to blood 
supply (Hsiu 2012) 
-- -- 
The magnitude from these spectral ranges was obtained for each phase and 
compared.  The mean estimator was calculated for each phase.  And a cumulative 
estimator was calculated with all trials. 
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EKG.  The spectral estimation of the EKG was performed as above with the PPG 
and LDF data.  However, the estimators were of different ranges and the LF/HF ratio 
was used to provide a measure of heart rate variability (Henley 2008)(Lewis 2005) 
(Delaney 2001). 
 Low Frequency (LF) [0.04-0.15 Hz]. :  sympathetic activity 
 High Frequency (HF) [0.15-0.4 Hz] :  parasympathetic activity 
 
Figure 22:  LFHF Ratio 
The following calculations were completed for Low Frequency (sympathetics) 
and High Frequency (parasympathetics).  This method was validated with the Biopac 
ACQKnowledge software HRV function, documented in the appendix. 
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Statistical Analysis 
Group Stratification 
The raw data showed a decaying trend in blood flow in the control group.  The 
active group did not display a decline; rather the signals maintained a PPG PP value 
and fluctuating LDF MV.  A subset of the active group displayed enhanced responses 
during OMT.  This subset was termed the Peripheral Responders. The figure 
belowFigure 23 shows a representative PPG waveform from each group. 
 
Figure 23: Peripheral Responder - Comparison Left PPG data sets showing control 
(Subject 07), active (Subject 18) and peripheral responder (Subject 14). 
 
Similarly, the heart rate calculations showed varied responses among 
subjects.  The control group showed little change in heart rate throughout the 
session, the Active group heart rate fluctuated throughout the session.  And a subset 
of the Active group showed a decrease in heart rate during OMT.  This subset was 
termed the Central Responder group.   
The Control group results were compared to the Active, Peripheral Responder 
and Central Responder groups to determine statistical significance. 
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Figure 24: Central Responder.  Comparison of Control (top), Active (middle) and 
Central Responder (bottom) Groups 
Mann-Whitney U Test 
A parametric and a non-parametric statistical analysis technique were used.  
The non-parametric method was used due to the sample size (less than 20 samples 
per group).  The Mann-Whitney U test is a conservative approach as it has no 
assumptions regarding dependency and data (the rank order) is ordinal.  It also used 
because the data was not always normally distributed.  The Mann-Whitney U test 
ranks the means in an order and calculates the mean of the rank order.  Significance 
between the mean rank orders is determined.   
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Repeated Measures Analysis of Covariance (RMANOVA) 
A RMANOVA between-group test was completed for the mean trend of phases 
7-15 on the spectral estimation results.  Assumptions to use this statistical analysis 
were ignored; the analysis was completed with the intent that this is an exploratory 
study only.  Statistical analysis descriptions are found in the appendix.   
Percent Change Assessment 
Because the variability between subjects was so high the treatment effect 
could be masked.  For example, during a treatment Subject A may have an increase 
in a biophysical measure, Subject B may also have an increase but to a lesser 
degree, and Subject C may have a decrease in response to the treatment that is 
greater in magnitude than subject A and B.  In this illustration two out of the three 
subjects experienced an increase; however, the calculated mean of the three may 
show that there was no effect.  The treatment effect could be masked due to 
physiologic differences rather than therapeutic intervention.  To address this issue, 
another assessment of treatment efficacy was completed by showing the percent of 
subjects with a change.  The percent change for a measure described above was 
calculated per subject.  Any change less than ± 5% was considered as no change 
(NC), otherwise it was reported as increase (INC) or decrease (DEC).  The total 
number of subjects with an increase, decrease or no change was tabulated and 
reported as a percentage of the group.  Percent change assessment was completed 
for all results. 
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Error 
The parsed data from the master and slave were not extracted from the exact 
times.  One reason for this was because it was difficult to match up the data sets.  
One reason was due to noise and disturbance from different sources.  The peripheral 
sensors may have had noise interference from subject movement and the EKG data 
would not have any noise interference at that same time, and vice versa.  Also, it 
was difficult to match the EKG and PPG/LDF data due to the fact that the recorded 
time stamps were not the same.  First, the start times of the two data sets were 
different so the time delay between start and a certain phase was slightly off.  
Second, the clocks on the computers were not set to the same time, so that the 
recorded time of day between the two datasets was off.  Mid-way through the study 
the clocks on the two computers were synchronized so that the exact time of data 
capture would be known.  However, the difficulty remained due to the fact that there 
is a very slight delay on the trigger between the master and the slave.  Also, it is 
known that the electrical activity of the heart and the mechanical activity of the 
peripheral vasculature have a delay, due latency period between electrical impulse 
and myocardium activation and to wave propagation through resistive systemic 
vasculature (Rhodes 1996).  Attempts to align the data to the 0.01 second became a 
best guess.  It was decided that having the data match exactly would not add 
necessary information to the study at this point. For the purpose of this study it was 
sufficient that the data from master and slave were taken from the same phase, but 
not at the exact times. 
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CHAPTER 4 
METHODS AND THEORY:  SPECTRAL DOPPLER ULTRASOUND STUDY 
A capability was developed at ASTU SOMA, for acquiring long term data from 
a L500A Vista AVS unit from Summit Doppler System (Makin and Hope 2012).  The 
purpose of the spectral Doppler ultrasound study was to perform a reliability and 
feasibility test.  This chapter describes the device and post processing algorithms.   
Setup and Procedure 
The modified Vista unit fed the raw data into a LabVIEW based data 
acquisition program, which then output the data as text file format.  The data was 
post processed with Matlab scripts.  A probe positioner was designed to hold the 
Doppler probe at a 60 degree angle to facilitate continuous measurements.  In this 
experiment a subject lay supine as the facilitator performed systemic perturbation, 
and an operator conducted the data acquisition.  No OMTs were performed.  Blood 
flow from radial and the dorsalis pedis arteries were monitored in individual tests, as 
only one modified Doppler unit was available. 
 
Figure 25:  Spectral Doppler Ultrasound Study Setup (top), probe holder (bottom 
left), radial artery probe position (bottom middle), and dorsalis pedis artery probel 
position (bottom right) 
 60 
The protocol for this study included two reactivity tests, namely occlusion and 
limb elevation.  The occlusive phase used a cuff around the limb proximal to the 
probe, where the cuff was inflated to above 60 mmHg for 90 seconds.  In the 
posture phase, the aim was to elevate the artery above the level of the heart.  For 
the radial artery test the arm was raised vertically, and perpendicular to the body.  
For the dorsalis pedis artery test a modified Trendelenburg position was used, where 
the legs were raised bending only at the hip.  A cushion and block were placed under 
the subjects’ calves to assist the subject in maintaining position without exerting 
effort.  This also helped to prevent bending at the knee which might cause occlusion 
of the vessels. Each test was approximately 20 minutes in duration, with three 
minute rest phases and 1.5 minute active phases.  The table below shows the 
procedure order. 
Table 4 
Spectral Doppler Ultrasound Protocol  
 
A total of 5 sessions, with 3 male and 1 female, asymptomatic subjects were 
conducted.  The table below contains the session data.  The first two sessions were 
experimental informal procedures and were not included in the final analysis. 
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Table 5:   
Doppler Ultrasound Project - Subject Data Table 
 
Spectral Doppler Ultrasound and Applications 
The Vista AVS is a commercial, point of use diagnostic tool that is used for 
assessing peripheral arterial disease (PAD).  The devices measures the ankle brachial 
index (ABI), or ankle brachial pressure index (ABPI), to diagnose PAD.  The ABI is 
the ratio between the ankle pressure and the brachial pressure. A normal circulation 
will have a higher pressure in the ankle.  The ratio provides an index of peripheral 
health, where ABI >=1 is normal, and ABI <=0.8 signifies arterial impairment, and 
ABI< 0.5 indicates severe PAD.   
The pressure from an artery is obtained by inflating a cuff proximal of the 
probe until the arterial pulse is zeroed.  The cuff is slowly deflated releasing 
pressure.  The cuff pressure at first return flow is defined as the arterial pressure.  
The pressure in the Dorsalis pedis can be difficult to obtain.  In the presence of PAD 
dorsalis pedis pressure can even be confused with the clinician’s finger pulse when 
palpating.  Several pedal arteries can be used to for the ankle pressure.  These are 
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the Dorsalis pedis, peroneal, anterior tibial and posterior tibial arteries, for example 
(Eagle 2006). 
This ABI method does have limitations in that it is operating under the 
assumption that the upper extremity circulation is normal.  This assumption is due to 
the fact that PAD generally occurs in the lower limbs first.  False positives may arise 
if PAD is present in the upper limb. The upper limbs circulation could be poor yet the 
ABI ratio would show as normal.  Also, it is often the case that the brachial arteries 
on either arm have different pressures.  A false positive may result in the event that 
pressures from both arms are not measured. 
Sensor Operation  
The Doppler ultrasound device uses the Doppler Effect to detect the velocity 
of the red blood cells, providing a measure of blood flow.  The probe emits an 
ultrasonic wave, a sound wave above >20,000 Hz, into the tissue.  The incident 
beam hits red blood cells suspended in plasma and the sound is scattered radially 
from the particle.  The scattered wave from the RBC in motion changes frequency in 
proportion to the speed of the RBC.  The ultrasonic wave incident on this frequency 
produces a beat frequency whose amplitude and frequency also change with respect 
to speed of RBC.  This beat frequency produces a sound wave whose pressure causes 
a piezoelectric element in the Doppler ultrasound probe to distort.  The piezoelectric 
element thus converts the frequency to a voltage.  The ratio of the speed of sound in 
through the medium and the thickness of the element determine resonance.   
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The resonance of the element is defined as the “Q” factor.  The Q factor is 
determined by the manufacturer. 
𝑄 =
𝑓𝑜
∆𝑓
       (5) 
where, ∆𝑓is the full width half bandwidth value of the spectrum.( Azhari 2010) 
The unit provides audible and a quantitative plot outputs.  The echoes 
normal1 to RBC velocity are within human hearing range and are therefore amplified 
and output from the unit.  The audible sound wave indicating blood flow changes are 
used by the clinician to adjust probe position and used in subsequent clinical 
diagnostics.  A visual output is also provided by the device.  The echoes collected by 
the probe transducer are amplified and mixed at 90o phase change with the incident 
beam.  The phase change, rather than the magnitude of the frequency, of the 
amplified echoes are used to obtain the velocity.   
The Doppler shift equation is used to relate the shifted frequency to the 
velocity of the particle.  An equation for the Doppler frequency related to velocity 
was provided (Reid 1987): 
𝑣𝑐𝑜𝑠𝜃 = 𝐾𝑓𝑑,     (6) 
where,    𝑓𝑑 = 𝑓𝑡 − 𝑓𝑟, 𝐾 = 0.5 ∗ 𝑐 ∗ 𝑓𝑡
−1 
And v = radial velocity of incident object, fd = Doppler shifted frequency, f t= 
transmitted frequency, fr = received frequency, c = speed of the incident beam 
through the tissue,  = angle between the forward velocity and line of sight between 
the probe and the incident object.   
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The ultrasonic interaction with the tissue and RBC is much more involved, as 
waves reflect and scatter off stationary tissues, fluids and multiple cells traveling at 
different velocities.  Different devices use different techniques to account for all of 
these.  To simplify, the circuit design uses a high pass filter to remove the input from 
the tissues and slower moving cells at the vessel wall.  A low pass filter is used to 
detect the difference between the incident and reflected waves.  The two filter 
outputs provide a real and imaginary component of a signal when mixed in 
quadrature.  The signal is Fourier transformed to provide the output displayed on the 
screen.  The value of the output, however, is in arbitrary units of mV.  A scaling 
feature on the unit allows the signal to be viewed optimally. 
Spectral Doppler Ultrasound waveform and Characterization 
The peak velocity in the Doppler waveform is due to ventricular systole and 
the minimum velocity is due to ventricular diastole.  The phasic characteristic of the 
signal is indicative of arterial dysfunction.  A normal artery will have a triphasic 
waveform with forward, then reverse then forward signal.  A biphasic signal has 
forward and reverse signal, and a monophasic signal has forward only, indicating 
loss of arterial compliance.  The raw Doppler data from the LabVIEW output was 
separated into the forward and reverse Doppler components.  These were 
determined by the direction of blood flow with respect to the probe, where forward 
represents flow towards the probe and reverse represents flow away from the probe.   
Differences were noted between the radial and dorsalis pedis artery data.  
The radial arterial flow was DC shifted in 5 out of 6 subjects, such that the reverse 
component was lost, yet the entire triphasic waveform was represented.  The 
dorsalis pedis waveform was entirely distributed about the zero axis such that there 
was no loss of reverse of forward flow at any time. Only one subject showed a loss of 
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reverse flow in dorsalis Pedis, which only lasted for a few seconds, and was thus 
considered an outlier.  The dorsalis pedis artery also had biphasic waveforms, 
whereas the radial artery did not.   
Post Processing 
The Doppler ultrasound data was analyzed in the time and frequency domain.  
The forward and reverse Doppler signals were combined into one signal.  This was 
completed by a point by point addition of the two signals.  The figure below 
illustrates the separate and combined signal for both arteries showing no loss of 
waveform. 
Figure 26:  Combined Doppler Signal. Forward Doppler (FwDOP) + Reverse Doppler 
(RvDOP).  (Top) Dorsalis Pedis shows no loss of reverse flow.  (Bottom) Radial artery 
shows loss of reverse flow. 
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Data parsing 
The first and last 5% of data was excluded to avoid periods of subject 
movement between phases, so only 90% of the data in the phase was analyzed.   
Time Domain Analysis 
Signal characterization.  A peak detector was developed to isolate the 
cardiac cycles.  A histogram of the combined Doppler signal showed that the peaks 
were located in the upper 10% of the data.  This figure was used as a cutoff to refine 
the peak detector.  The cardiac cycle was then identified as the time between two 
peaks and the start of the cycle was set to the twenty points before the first peak.  
The peak systolic and peak diastolic velocity, average velocity, mean velocity (time 
averaged), pulsatility index, resistivity index, forward and reverse velocity and peak 
to peak (pp) were calculated for each cardiac cycle.  The mean was calculated for 
each phase.  And a cumulative estimator was calculated with all trials. 
 
Figure 27:  Spectral Doppler Ultrasound Indices 
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Frequency Domain Analysis 
Doppler ultrasound waveform is composed of multiple frequency components.  
A DC shift was expected to be prominent in the radial artery.  Low frequency 
components from slow wave were also expected to be more prominent in radial 
artery, based upon a slow wave observed in the raw data.  A frequency component 
due to cardiac rhythm and higher frequencies resulting from heart rate variability 
and cardiac activity are also expected, and observed within a cardiac cycle as time 
between peak systole and dichroitic notch for example.  Harmonics due to effects of 
local regulation on blood flow which increase with distance away from heart are also 
expected.  Spurious peaks due to noise and filter leakage were also expected. 
The sampling time of the Vista AVS-LabVIEW setup was reported to be “40Hz with a 
noise floor of 8 mVrms” (Makin and Hope 2012).  For the following spectral analysis 
the sampling time from all sessions was calculated.  The mean sampling time was 
found to be 0.013 seconds per sample, with a sampling frequency of 74.6 Hz.  The 
sampling frequency used in the subsequent analysis was 75Hz.   
Based upon the available length of data sets, the highest achievable 
frequency resolution was 0.01 Hz.  This requires which needs 109.2 seconds of data, 
or 8192 samples, providing an FFT size of 2^13.  Since the experiments were of only 
20 minutes in duration subject movement was minimal and noisy data sets were not 
an issue.  Therefore, data parsing was not necessary and 10.92 seconds of 
continuous data was selected.  Several preset transform windows in Matlab were 
compared and a Chebyshev filter with lobe attenuation of 300dB was selected.  The 
windowed data was zero padded as necessary.  The power of the FFT was calculated 
to obtain the final PSD.  The max peak at 1 Hz (heart rate) from the entire session 
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was selected as the normalizing factor.  The change in spectral content can then be 
viewed with respect to the peak within the session. 
 
Figure 28: FFT Filters.  Chebyshev window with r=300 dB lobe attenuation shown in 
black dashed line 
 
Figure 29:  Normalized PSD of final rest phase of Subject 07 Radial Test, normalized 
to 1Hz peak. 
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CHAPTER 5 
RESULTS 
The results from the Biopac project and Doppler ultrasound project are 
reported in this chapter.  Further discussion and interpretation of results is found in 
Chapter 6. 
Peripheral Flow Results 
Bilateral Response 
The blood flow signals showed a bilateral response in the raw data.  A test on 
the data acquisition system was performed and concluded that this was not a 
systemic error.  The results of this test are documented in the appendix.  Figure 30 
shows raw data from Subject 25 resting phase where the PPG signal amplitude and 
LDF MV and PP were greater in the right hand compared to the left hand.  The right 
hand blood flow parameters were greater in the right hand in most subjects. 
The cumulative time and frequency domain results showed similar bilateral 
responses, where right hand flow parameters were greater in the right hand 
compared to the left.  The figure below shows the time domain RMS calculations for 
the LDF signal (left) and the frequency magnitude of the LDF signal (right).   
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Figure 30:  Bilateral response in Subject 25 Rest 6 Phase 60 seconds of data.  The 
PPG and LDF plots have the same y-axis scales.  The right hand PPG is centered at -
0.04 rather than 0. 
 
 
Figure 31: Bilateral response was seen in the cumulative results of the time domain 
analysis and frequency domain analysis (Left) LDF RMS values.  (x-axis ) phase in 
session, (y-axis) RMS value in blood perfusion units (BPU), ‘*’ items denote OMT 
phases. (Right) LDF Frequency Magnitude of plot from 0-10 Hz. (x-axis) phase in 
session, (y-axis) frequency magnitude in dB. 
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Trends 
Control Group.  For the control group, the time and frequency domain 
analysis of the blood flow parameters resulted in a similar asymptotic decaying 
trend.  The difference in flow parameters between the left and right hand diminished 
as the control session progressed.  The variability in the calculations also decayed.  
The figure below shows the PPG RMS calculations and the frequency magnitude from 
0-10 Hz of the control group.   
 
Figure 32:  Control Group Trend. Asymptotic decaying trend in the time and 
frequency domain analysis.(left) left and right PPG RMS time domain analysis of 
control group;  (right) frequency magnitude plot of left and right PPG of the control 
group. 
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Active Group.  The time and frequency analysis results of the active group 
showed that the blood flow parameters maintained signal strength as the session 
progressed.  A light decay in signal is observed from initial to final phase; however 
this trend shows less decay than the control group.  The active group also showed an 
increasing bilateral response during some OMT.  The variability in the data does not 
decrease it did with the control group.  The figure below shows the PPG time (RMS) 
and frequency domain (0-10 Hz) analysis.  The right hand shows increases during 
from T8-L2 (phase 12) till the end of the session.   
 
Figure 33:  Active Group Trend. (left) PPG RMS time domain analysis of active group;  
(right) PPG frequency magnitude plot of the active group. 
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Peripheral Responder Group.  The peripheral responder group trend did 
not decay as did the control group active group.  The signal was maintained, as seen 
in the time and frequency domain analysis results below.  The values during OMT 
(phase 8, 10, 12, 14).   
 
Figure 34:  Peripheral Responder group trend.  left) LDF RMS time domain analysis;  
(right) LDF frequency magnitude plot. 
There was no statistical significance within group trends for any group.   
Percent Change.   
The number of subjects that showed an increase or decrease from rest to 
active phase is shown in Table 18, where of the signal characteristic changed by at 
least 5% to be considered an increase or decrease.   
In all groups a majority of subjects experienced a decline in blood flow signal 
from initial to final phase of session, excluding the peripheral responder group where 
60% had an increase in PPG and Volume RMS in the right hand.   
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During OA-C2, the majority in all active groups had an increase in PPG, LDF 
and Volume RMS, excluding the right hand volume RMS where 50% of active group 
decreased, and half of the central responders increased and half decreased.    
During T1-T4 the active group has a decrease in both hands in all blood flow 
signal characteristics.  The responder group’s percent of increases and decreases 
varied across signal characteristics. 
During T8-L2 a majority of active subjects increase in all blood flow signal 
characteristics.  The majority of peripheral responders did as well.  The majority of 
central responders showed increases in all signal characteristics excluding LDF RMS 
where the majority decrease in the left hand, and half increase and half decrease the 
right hand.   
During L5-S all active subjects have a majority of subjects that have 
increased PPG RMS and decrease in LDF RMS.  The majority of active subjects have a 
resulting decrease in Volume RMS for both hands.  The majority of peripheral 
responders had increases in PPG, LDF and Volume RMS in both hands.  The majority 
of central responders had increases in all blood flow characteristics excluding right 
hand LDR RMS, where majority of the group decreased. 
Statistical Analysis 
Responses also varied from subject to subject.  The PPG and LDF and Volume 
PP, RMS and MV values had a large degree of variability.  The variability was much 
smaller in the control group.  The Control group’s blood flow trends decreased 
steadily throughout the session on both sides of the body.  The flow signals decrease 
by about 50% in both PP and RMS values.  For Active groups the decay in blood flow 
was to a lesser degree.  Instead, the flow was maintained throughout the session.  
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The Peripheral Responder group had enhanced responses during OMT.  The Central 
Responder group showed no decay, and had enhanced response in the PPG results 
during three OMTs.  A statistical analysis of the RMS values for all groups showed 
that the mean slope of the Active compared to the Control group, from phase 7 and 
on, was statistically significant.   
Table 6 
Mann-Whitney U statistical analysis results, comparing phases between groups. 
 
Frequency Components 
Overview.  The PSD of the PPG and LDF signal shows peaks within 0 to 4 Hz.  
After 4 Hz the spectra attenuate. The PPG signal had the greatest magnitude around 
1 Hz, and the LDF signal had the greatest magnitude around 0 Hz. For the control 
group, the peaks beyond the 1.5Hz fundamental decayed as the session progressed.  
In the Active group, the frequency components above 1.5 Hz did not decay 
LtPPG RMS Control vs. 
Active
Control vs. 
Peripheral 
Responder
Control vs. 
Central 
Responder
RtPPG RMS Control vs. 
Active
Control vs. 
Peripheral 
Responder
Control vs. 
Central 
Responder
OA-C2 0.006** 0.004** 0.035* OA-C2 0.007** 0.036* 0.009**
T1-T4 0.014* 0.015* 0.056 T1-T4 0.009** 0.020* 0.021* 
T8-L2 0.026* 0.020* 0.027* T8-L2 0.000** 0.003** 0.002**
L5-S 0.007** 0.003** 0.016* L5-S 0.000** 0.002** 0.001**
LtLDF RMS Control vs. 
Active
Control vs. 
Peripheral 
Responder
Control vs. 
Central 
Responder
RtLDF RMS Control vs. 
Active
Control vs. 
Peripheral 
Responder
Control vs. 
Central 
Responder
OA-C2 0.044* 0.012* 0.006** OA-C2 0.003** 0.002** 0.007**
T1-T4 0.018* 0.003** 0.159 T1-T4 0.003** 0.002** 0.016*
T8-L2 0.020* 0.002** 0.366 T8-L2 0.000** 0.002** 0.012*
L5-S 0.009** 0.002** 0.228 L5-S 0.001** 0.002** 0.012*
HR Control vs. 
Active
Control vs. 
Peripheral 
Responder
Control vs. 
Central 
Responder
HRV Control vs. 
Active
Control vs. 
Peripheral 
Responder
Control vs. 
Central 
Responder
OA-C2 0.490 0.062ⱡ 0.763 OA-C2 0.587 0.865 0.763
T1-T4 0.622 0.100ⱡ 0.922 T1-T4 0.402 0.533 0.228
T8-L2 0.521 0.079ⱡ 0.688 T8-L2 0.490 0.336 0.191
L5-S 0.374 0.079ⱡ 0.841 L5-S 0.490 0.692 0.615
 76 
throughout the session.  The peripheral and central responders showed increases in 
bandwidth of the frequency components above 1.5 Hz during OMT. 
 
Figure 35: PSD results for left LDF, showing all groups.  , x-axis shows time in 
phases, y-axis is frequency in Hz, and color scale shows intensity of spectral density 
in db.  Control Group (top left) , Active group (top right), Peripheral Responder group 
(bottom left), central responder group (bottom right) 
 77 
 
Figure 36: LDF Frequency magnitude from 0-10 Hz 
Components.  The frequency components of interest occurred in three 
ranges, 0-0.5 Hz, 0.5-1.5 Hz, and 1.5-3 Hz.  . 
Figure 37 and Figure 38 show the results of the PPG and LDF frequency 
component analysis, respectively.  For these plots the right and left hand trials were 
combined for ease of viewing.  But the analysis and statistics were calculated 
separately for each hand.   
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Figure 37:  PPG Frequency Magnitude (left and right hands combined) of range 0-0.5 
Hz, 0.5-1.5 Hz, and 1.5-3.0 Hz. 
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Figure 38:  LDF Frequency Magnitude (left and right hand combined)of range 0-0.5 
Hz, 0.5-1.5 Hz, and 1.5-3.0 Hz. 
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Table 7 
RMANOVA analysis of Frequency Magnitude, Active compared to Control group 
 
 
The magnitude of the PPG signal in this range from 0-5 Hz showed that the 
control and the active group had approximately the same mean throughout the 
session.  The responder groups had increased magnitudes during the OMT phases.  
Central responder group had a greater magnitudes throughout the session compared 
to other groups only in this range, in this signal, during OA-C2, T1-T4 and T8-L2.  
For all other OMT and frequency ranges, both LDF and PPG, the peripheral 
responders had the greatest magnitudes.   
The LDF results were 3 orders of magnitude greater than the PPG results in 
this range.  Also, LDF frequency components above 0.5 Hz are three orders of 
magnitude lower than the slow wave component (0-0.5 Hz).  This is due to the DC 
shift in the signal.   
PPG frequency components above 0.5 Hz and all frequency components for 
LDF showed that the control group magnitudes attenuated as the session 
progressed.  The active group maintained a mean spectral content and the responder 
Frequency Magnitudes
Active compared to Control
p-values RMANOVA analysis
Left Right
PPG [0-0.5 Hz] 0.170 0.550
PPG [0.5-1.5 Hz] 0.004** 0.048
PPG [1.5-3 Hz] 0.001** 0.03*  
LDF [0-0.5 Hz] 0.001** 0.006**
LDF [0.5-1.5 Hz] 0.010** 0.003**
LDF [1.5-3 Hz] 0.014* 0.003**
*p<0.05, **p<0.01
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groups had increased magnitudes in the OMT phases.  Also, for these the group with 
the greatest magnitudes was the peripheral responder group.   
The spectrum from 1.5 to 3Hz had a greater magnitude in PPG compared to 
LDF, where the active group mean from phase 7-15 for PPG =3.38e-1±0.1 and LDF 
=4.68e-1±0.05, and peripheral responder group mean from phase 7-15 was 
PPG=5.89e-1±0.29 and LDF= 6.12e-1±0.12. 
 
Figure 39:  PPG and LDF frequency magnitude from 1.5-30 Hz. 
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EKG Results 
Heart Rate 
The heart rate in the control group was about 65 BPM throughout the session.  
The active group showed some fluctuations as the session progressed.  A slight 
decrease was noted in OA-C2 (phase 8) and T1-T4 (phase 10).  The responder 
groups showed greater fluctuations during the session.   The central group showed 
the greatest decreases in heart rate during OMT, with T1-T4 showing the greatest 
decrease of 5BPM.  The central responders’ heart rate returned to the initial heart 
rate by the end of the session.  The peripheral responder group showed the greatest 
decrease in heart rate from start to end of session, at about 4BPM.  This group also 
started out with the highest heart rate at 74 BPM.   
 
 
Figure 40:  Heart Rate [BPM] of control, active and responder groups. 
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Table 8 
Change in heart rate [BPM] from prior quiescent phase. 
 
The number of subjects per group that had an increase, decrease, or no 
change (less than 0.5 BPM increase or decrease) is shown in Table 9.  The control 
group showed no dominant trend throughout the session.  The number of increases, 
decreases or no change was spread throughout the subjects.  The dominant trend in 
the Active group was a decrease in three of the four OMTs.  60% of the Peripheral 
Responder group showed decrease from start to end of the session.  All of the 
subjects in the Central responder group showed a decrease in heart rate in all OMTs 
excluding T8-L2 where 83% decreased.  The Central Responders had an increase in 
heart rate from start to end of the session.   
Table 9 
Heart Rate Percent Change:   Subjects with Decrease, Increase or No change (<0.5 
BPM) in heart rate from initial to final phase and from rest to active phase. 
 
The mean heart rate of the control group was approximately 65 BPM 
throughout the session.  The active group’s heart rate increased and decreased 
throughout the session, between 65 and 70 BPM.  The overall change in heart rate 
reduced nearly 2 BPM.  The central Responder group had a reduction of 3BPM during 
each OMT, from approximately 68 to 65BMP each OMT.  The starting and ending 
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heart rate was 70 BPM for this central responder group.  The peripheral responder 
group had changes in heart rate throughout the session, with an overall decrease 
from start of session at 74 BPM down to 70 BPM by the end of the session.  This was 
the greatest decrease in heart rate of all the groups.  The central responders showed 
the greatest decrease in heart rate during all OMTs, with the greatest reduction 
occurring in the OA-C2 treatment.   
Heart Rate Variability 
The heart rate variability was assessed by calculating the normalized 
frequency magnitudes of low and high frequency.  The heart rate variability is the 
ratio of low to high frequency magnitudes.  
Low frequency 0.04-0.15 Hz.  The active group showed a decreased 
magnitude for all OMTs, except for T8-L2; however the variability did increase during 
this phase.  Both responder groups decreased during OMT phases.  From phase 9 
and on the Peripheral Responder group had greater frequency magnitude compared 
to the Central Responder.  This range is associated with the sympathetic activity, 
and this decreased during OMT for active and responder groups, excluding T8-L2.   
High frequency – 0.15-0.4 Hz.  The Active group had increased 
magnitudes for all OMT except T8-L2 where the magnitude did not change from the 
prior rest phase.  The variability did increase during this phase.  The central 
responder had a greater magnitude than the peripheral responder from phase 9 and 
on.  This range is associated with parasympathetic activity, and this increased during 
OMT, excluding T8-L2.   
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LFHF Ratio.  LFHF ratio increased during OA-C2 and T8-L2, and decreased 
during, T1-T4 and L5-S.  In the peripheral responder group the ratio decreased 
during all OMT phases.  In the central responder group the ratio decreased for all 
OMT phases excluding T8-L2.  The peripheral responder group had a higher ratio 
from phase 9 and onward.   
 
Figure 41: LF and HF of EKG. Low frequency (sympathetic) and high frequency 
(parasympathetic). 
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Figure 42:  Heart Rate Variability 
Summary of Biopac Study Results 
The table below summarizes the results from the Biopac study.   
Table 10 
 Summary of Results Table 
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Spectral Doppler Ultrasound Results 
The radial artery and dorsalis pedis artery test were conducted separately.  The 
figure below shows the raw data sets from test subject 03. 
 
Figure 43:  Subject 03 spectral Doppler Ultrasound dorsalis pedis (top) and radial 
artery (bottom) test.  The y-axis is in units of mV. The x-axis is time in seconds. 
Upper and Lower Extremity Differences 
The output from the upper and lower extremity arteries showed different 
physiologic output.  Figure 44 illustrates this.  The radial artery has greater 
amplitude than the dorsalis pedis artery.  In this example, the radial artery is 
triphasic and the dorsalis pedis artery is biphasic. 
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Figure 44:  Radial and Dorsalis Waveform Comparison.   Subject 6 rest phase,  radial 
artery test (left) with a triphasic waveform, dorsalis pedis artery test (right) with a 
biphasic waveform 
Furthermore, during the sessions, the radial artery data intermittently 
displayed loss of reverse flow in all but one subject.  The triphasic waveform was still 
present indicating no loss in vascular function  The dorsalis pedis artery data did not 
show any loss in reverse flow during the experiments.  .  During the occlusive phase 
all subjects experienced a near zero blood velocity in both extremities.  The posture 
change resulted in an increased velocity in the lower extremity, but a decrease in the 
upper extremity. 
Time Domain Analysis 
Figure 45, in the appendix, provides the cumulative peak to peak 
measurements of the forward, reverse and combined Doppler waves.  Variability 
increased during the lower extremity posture change.  Also during the posture 
change in the dorsalis pedis tests the peak diastolic velocity decreased more than the 
peak systolic velocity increased.  The change in diastole contributed to the combined 
Doppler peak to peak increase.  During the posture change in the radial artery tests 
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both peak systolic and diastolic velocities decreased.  The overall peak to peak 
velocity decreased was due to changes in both systole and diastole.   
 
Figure 45:  Peak to Peak Results.  Dorsalis Pedis test (top), Radial Artery test 
(bottom).  The x=axis shows the phases in the session: 1=Rest1, 2=Occlusion, 
3=Rest2, 4=Posture Change, 5=Rest.  Y-axis is the velocity in mV. 
Frequency Domain Analysis 
PSD results also varied from subject to subject.  Some subjects showed 
greater spectral strength in the radial artery while other had a greater spectral 
strength in the dorsalis pedis artery.  This could be due to physiologic differences 
between subjects.  It may also be artifact of sensor position and contact.  Figure 46 
compared PSD results of subjects 4 and 6.  Subject 4 had a greater spectral content 
in the lower extremity while Subject 6 had greater spectral content in the upper 
extremity. 
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Figure 46:  PSD Comparison between two subjects.  These subjects show spectral 
content differences between extremities.  (top) Subject 4 dorsalis pedis and radial 
artery PSD, (bottom) Subject 6 dorsalis pedis and radial artery PSD. 
Cumulative Results.  The radial artery had a wider spectral content spread 
compared to the dorsalis pedis artery.  The spectra started to attenuate at 6 Hz in 
the dorsalis pedis artery and started to attenuate after 10 Hz in the radial artery.  
The magnitude of the frequency in the initial rest phase was three times greater in 
the radial artery than the dorsalis pedis artery.  See  
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Figure 47 and Figure 48 for the PSD images and Magnitudes respectively.  
The spectral content attenuated during the occlusive and posture change 
phases for both arteries.  The dorsalis pedis artery showed less change from phase 
to phase compared to the radial artery.   
 
Figure 47:  Cumulative Power Spectral Density of dorsalis pedis artery tests (left) 
and radial artery tests (right).  The x-axis indicates the phase in the session. 
 
Figure 48:  Frequency magnitude from 0-10Hz, for each phase. 
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CHAPTER 6 
DISCUSSION 
Vascular responses are in the purview of autonomic regulatory mechanisms.  
The aim was to develop and implement a capability to profile this response for use in 
OMT research.  The two studies described obtained quantitative measurements at 
three different locations in the cardiovascular system sites.  The Biopac study 
investigated central activity and skin blood flow, and the spectral Doppler ultrasound 
project investigated segmental arterial flow.  These flow profiles were recorded 
during an OMT protocol and reactivity tests, and the responses were characterized.   
Bilateral Response 
The bilateral responses observed across the many analyses presented in this 
study were confirmed as non-artifact.  Rational for bilateral asymmetry in blood flow 
include metabolic differences between dominant and non-dominant hands, 
asymmetric drainage lymph flow, or perhaps asymmetric application of treatment.  
Further analysis would be required to determine the reasons for this, as dominant 
had of subjects and symmetry of treatment were not recorded.  The cumulative PPG 
results and control groups did not show as distinct of a bilateral response, however, 
it should be mentioned that the response could be seen within the individual raw 
data sets.  The lack of DC and slow wave components in the PPG signal due to the 
HPF may have masked the bilateral response in the cumulative results.   
  
 93 
Effects of OMT 
Time wave Characteristics of Peripheral Flow 
To obtain an improved flow blood pressure must increase and systemic 
resistance must decrease.  Blood pressure changes could be a due to 
parasympathetic activity at the SA node decreasing heart rate, allowing more time 
for the ventricle to fill during diastole thereby ejecting more blood.  It could also be 
due to increased extent or rate of contractility resulting from sympathetic activation 
in the ventricle.  Sympathetic activation in the blood vessels also reduces systemic 
resistance.  The effects observed during OMT showed that a combination of 
sympathetic and parasympathetic activation may have occurred in different areas of 
the heart and sympathetic activity may have occurred in the vascular system.   
Table 11 
Summary Inc/Dec/NC:  Time wave characteristic changes from prior quiescent  
phase to OMT.  Active/peripheral responders/central responders. 
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Frequency Components of Peripheral Flow 
The increase in spectral content is due to a combination of AM and FM 
modulation of the carrier frequency, or HR.  Increased spectral content due to 
increase in sidebands are due to FM modulation, or activity from the SA node.  AM 
modulation is due to myogenic activity, resulting in an increased carrier frequency 
magnitude and decreased sidebands.  AM and FM modulation are additive (Kamal 
1989).   
In the active group, bandwidth and magnitude increased in the slow wave, 
fundamental and harmonic components.  The peripheral responders had greater 
spectral content in the 0.5-1.5 Hz range, indicating that treatments resulted in AM 
modulation, or by local sympathetic induced myogenic activity.  Central responders 
had greater spectral content below 0.5Hz during OMT, indicating that treatments 
resulted in FM modulation, or parasympathetic influenced SA activity.   
The most noticeable changes of all frequency ranges analyzed were in the 
harmonics.  These components were present in the active group and decayed in the 
control group.  In the responder groups the spectral content increased in magnitude 
during OMT.  Per Hsiu et al. (2012), the harmonic components in the PPG PSD are 
coordinate with blood pressure wave from the radial artery.  As blood pressure wave 
increases, more blood is supplied to the finger pulp, and coordinately, the harmonic 
content increases.  Using this rational, we could say that microvascular blood flow 
increased during OMT.  However, this would need to be validated.  The spectral 
Doppler ultrasound device combined PPG sensor could be used to validate this in a 
future study. 
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HR and HRV 
The EKG analysis showed that the heart rate did change during OMT.  The 
peripheral responder group had the most elevated initial heart rate, at a mean of 74 
BPM.  As described earlier, an elevated heart rate indicates somatic dysfunction.  
Therefore, to the clinician, subjects with greater initial heart rates have the most to 
gain from therapy.  Furthermore, the peripheral responders experienced the greatest 
decrease in heart rate post session, ending at 70 BPM.  For both responder groups, 
HR decreased during OMT.   
Changes were noted in HRV, yet there was no dominant trend.  Dominant 
trends were in noted in the individual LF and HF ranges.  The LF magnitudes 
decreased during OMT and HF magnitudes increased during OMT, excluding T8-L2.  
Per the literature, this data described a decrease in sympathetic activity and increase 
in parasympathetic activity (Lewis 2005) (Delaney 2001) (Eur 1996).  Such 
autonomic changes result in decrease in heart rate, which is one goal of OMT.  
Henley et al. (2008) interpreted a steady HRV (from pre tilt, to tilt to post tilt), as 
sympathoexitetory inhibition, while Purdy et. al (1996) reviewed both blood flow 
parameters in coordination with HRV and attributed the trend to parasympathetic 
excitation.  As such, interpretations of the HRV results from this study are not 
conclusive.  We may only note that changes have occurred during OMT. 
Spectral Doppler Ultrasound Project 
In a proper Trendelenburg position, the table that the subject lies on should 
be tilted, so that the entire body is tilted at a 15-30 degree angle, with head down 
and legs above level of heart.  The purpose of the position is to use gravitational 
forces to improve venous return and improve load on the ventricles, thereby 
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increasing cardiac output and stroke volume.  It was originally developed in assisting 
with abdomen surgery.  It was classically used as a first aid in cases of shock and 
hypotensive patients.  Current studies disprove the effectiveness of the 
Trendelenburg position.  In one such study, the subject was inclined at a 6 degree 
position.  The expected hemodynamic effects in normal subjects did not persist 
beyond five minutes, and venous return was ultimately impeded, attributed to 
gravitational force on abdomen organs (Summers 2009).  In the Doppler ultrasound 
project, the subject was not tilted, but the legs were inclined at the hip, no bend at 
the knee.  The results from this lower extremity posture change showed changes in 
systole and diastole.  In the dorsalis pedis artery, diastolic peak decreased thereby 
producing an increased EDV.  The systolic peak increased, indicating that the blood 
ejected from the ventricle increased during posture change.  The resulting PP 
velocity increased, indicating that the contractility of the heart increased, where 
blood velocity improved.  The expected response was a slowing of blood velocity, and 
a smaller peak to peak value.  However, the actual results agree with literature on 
the Trendelenburg position (Summers 2009).  In the radial artery, both systolic and 
diastolic peaks decreased during posture change.  This result can be explained by an 
increase in systemic resistance due to gravitational forced on the blood in the upper 
limb.  The decreased blood pressure resulted from a decrease in ESV.  The PP 
velocity decreased, indicating that the contractility of the heart was decreased.   
Changes in systole and diastole represent autonomic activity of the heart.  
Heart rate is primarily dependent on changes in diastole (Rhodes).  Systole is 
primarily dependent on ventricular contraction.  In light of the reactivity tests 
performed, it was evident that the radial and dorsalis pedis arteries showed 
physiological differences, where the dorsalis pedis had a dampened blood velocity as 
compared to the radial artery.   
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Limitations 
Variability was high in this study, more so in the active group compared to the 
control group.  This variability even persisted in the subset responder groups.  This 
indicates varying subject to subject levels of blood flow and hemodynamics.  Also, 
the effects of OMT in asymptomatic subjects are expected to be subtle, as such, the 
high amounts of variability may masks the subtleties.   
Some aspects of the method were difficult to standardize.  For example, 
intensity of applied therapy required to attain homeostasis per subject differed.  In 
this study the standardization factor was the tenderness rating reported by the 
subject, which is a subjective measure and not qualitative.   
Sensors positioning and fastening was also difficult to standardize.  The 
sensors are highly susceptible to subject movement, sensor position and contact.  
Care was taken to apply the sensor in a way that would obtain the maximum signal 
strength.  However, this method was not standardized.  Gains in the software also 
varied based up on the subjects measured flow.   
Appropriate statistical analysis methods were could be further refined to 
better assess the trends seen in the frequency domain analysis.  The approach taken 
at this phase of the program was that one of an exploratory study and if assumptions 
regarding the sample size and normal distribution of data sets were met, the analysis 
would have been appropriate.   
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Future Work 
As this was a preliminary study, many improvements in experimental design, 
clinical procedure and data analysis were made evident throughout the study.  First, 
procedural improvements would enhance this study.  The hyperthermia wrap was not 
successful in most trials.  A better method of elevating the skin temperature would 
be needed.  Secondly, standardization of test methods and measurements would 
need to be discussed in full.  The inclusion of a sham and touch only procedures are 
often included in OMT research.  Future studies could be designed to understand 
sham itself, and then subsequently addition of sham to the protocol.  
Another area of improvement would be in the data acquisition system.  The 
data acquisition is highly dependent on sensor to skin contact.  A standardization of 
sensor positioning and fastening would strengthen the study.  Removal of the HPF on 
the PPG sensor would add the DC and slow wave components back into the 
waveform.  This may add relevant information on gross changes of blood pooling in 
the tissue.    
Experimental design changes would also serve to improve the study.  A larger 
sample population would increase statistical power.  Also, subject selection that 
included responders only may increase the power of the results.  Responders 
generally had higher heart rates (>70 BPM).  Further inclusion criteria for 
asymptomatic subjects who would be likely responders would need further 
discussion.   
A combined Biopac and spectral Doppler ultrasound technique in a singular 
study would provide broader vascular profile.  Effects on respiration, the right side of 
the circulatory system, would also increase the cardiovascular profile.   
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Further areas of improvement include post processing.  Spectral estimation 
techniques could be improved upon.  The main spectrum of clinical value is in the 
very low frequencies (< 0.1 Hz).  Lower frequencies contain cardiac activity that may 
provide more evidence of induced autonomic activity due to OMT.  Also, a focus on 
heart rate variability would be a logical next step in this study.  HRV is more and 
more used in clinical diagnosis and prognosis, and an advanced HRV analysis would 
certainly add value to understanding cardiovascular response to OMT effects.  Also, it 
would be of interest to examine the correlation between arterial blood pressure and 
harmonics >2Hz.  It is generally accepted that harmonics are of no clinical value 
(Kamal 1989).  However, the blood flow data in this study showed that harmonics 
persisted during active OMT.  Understanding of the harmonics would perhaps provide 
further information on the filtering, amplification and attenuating effects that the 
endothelium and precapillary sphincter on blood flow.   
Other areas of interest could further focus on the physiologic effects in 
asymptomatic subjects.  For example, the duration of the treatment effect is not well 
understood.  It is thought that the severity and chronicity of a subject’s ailment 
contribute to the efficacy and duration of the effect.  It would be interesting to see 
the duration of the effect after treatment over a group of asymptomatic responders, 
and then see how the effect duration varies in symptomatic subjects. Figure 1 below 
shows a subject with increased PPG PP value into the rest phase for almost 1.25 
seconds.   
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Figure 49:  Duration of treatment effect.  Subject 14: OA-C2 to Rest phase. 
Conclusion 
The present study investigated the role of OMT in cardiovascular responses.  
A clinical study was design for testing these effects.  Data analysis was completed for 
multiple biosignals.  Findings suggest that OMT produced significant peripheral flow 
changes from baseline.  Autonomic and non-autonomic effects were not isolated in 
this study so influences cannot be directly attributed to autonomic balancing.  
However mechanisms that induce these changes include autonomic mechanisms and 
suggest that they may be involved. 
 
  
 101 
REFERENCES 
[1] Abdollahi, Zahra, Justin P. Phillips, Panayiotis A. Kyriacou (2013).  Evaluation 
of a combined reflectance photoplethysmography and laser Doppler flowmetry 
surface probe.  35th Annual International Conference of the IEEE EMBS, July 
3-7.  Osaka, Japan. 
[2] Allen, John, Frame, John R, Murray, Alan (2002).  Microvascular blood flow 
and skin temperature changes in the fingers following a deep inspiratory 
gasp.  Physiologic Measurement,23,356-373.  
(http://iopscience.iop.org/0967-3334/23/2/312) 
[3] Allen, John. (2007). Photoplethysmography and its application in clinical 
physiological measurement. Physiological Measurement. 28:R1-R39.  
doi:10.1088/0967-3334/28/3/R01. 
[4] Almond, Nicholas E., Jones, Deric O. (1988).  Noninvasive measurement of 
the human peripheral circulation:  Relationship between laser Doppler 
flowmeter and photoplethysmograph signals from the finger.  Angiology, 39, 
819-829.   
[5] Anderson, Gunnar B. J., Lucente, Tracy, Davis, Andrew M., Kappler Robert, 
E.,  Lipton, James., Leurgans, Sue (1999).  A comparison of osteopathic 
spinal manipulation with standard care for patients with low back.  The New 
England Journal of Medicine, 34(19), 1426-1431. 
[6] Askenasy, J.J.M. MD, PhD, N. Askenasy MD, PhD. (1996) Inhibition of muscle 
sympathetic nerve activity during yawning. Clinical Autonomic Research. 
6:237-239. 
[7] Azhari, H. (2010).  Basics of Biomedical Ultrasound for Engineers.  Wiley-IEEE 
press.  DOI: 10.1002/9780470561478 
[8] Beraia, Merab (2010).  Arterial pulse impact on blood flow.  Health, 2(6), 
532-540.  doi:10.4236/health.2010.26080.   
[9] Bergstrand, Sara, Lindberg, Lars, Goran, Ek, Anna-Christina, Linden, Maria, 
Lindgren, Margareta .(2009).  Blood flow measurements at different depths 
using photoplethysmography and laser Doppler techniques.  Skin Research 
and Technology,15, 139-147.  doi: 10.1111/j.1600-0846.2008.00337.x. 
[10] Berntson, Bary G., Bigger, Thomas, Eckberg, Dwain L., Grossman, 
Paul, Kaugmann, Peter, G., Nagaraja, Haikady, N., Porges, Stephen W., Saul, 
Phillip J., Stone, Peter H., Van Der Molen, Maurits W. (1997).  Heart rate 
variability:  Origins, methods and interpretive caveats.  Psychophysiology 34, 
623-648.   
 102 
[11]  Boron, Walter F., Boulpaep, Emile L.(2012). Medical Physiology: A 
Cellular and Molecular Approach.  Philadelphia, PA: Saunders 
[12] Bracic, Maja, Stefanovska, Aneta (1998). Wavelet-based analysis of 
human blood-flow dynamics.  Bulletin of Mathematical Biology, 60, 919-935. 
[13] Brodal, Per (2010).  The Central Nervous System: Structure and 
Function, 4th edition.  New York, NY:  Oxford University Press. 
[14] Brolinson, Guunar P., McGinley, Sarah M. G., Kerger Shawn (2008).  
Osteopathic manipulative medicine and the athlete.  Current Sports Medicine 
Reports, 7(1), 49-56. 
[15] Celander, E., A.J. Koenig, D.R. Celender PhD. (1968). Journal of 
American Osteopathic Association. 67:1037-1038. 
[16] Christen, Samuel, Delachaux, Anne, Dischl, Benoit, Golay Sandrine, 
Liaudet, Lucas, Feihl, Francios, Waeber, Bernard (2004).  Cardiovascular 
Pharmacology, 44(6), 659-664. 
[17] Coulon, P., Constans, J., Gosse, P. (2012).  Impairment of skin blood 
flow during post-occlusive reactive hyperemia assessed by laser Doppler 
flowmetry correlates with renak resistive index.   Journal of Human 
Hypertension, 26, 56-63.   
[18] Early, Brian E., Luce, Helen (2010).  An introduction to clinical 
research in osteopathic medicine.  Primary Care Clinical Office Practice, 37, 
49-64. 
[19] Estrada, Christine, Varas, Grace, Busch, Gregory  (2010).  Osteopathic 
manipulative medicine in palliative care.  Journal of Pain and Symptom 
Management, 39(2),361-362.   
[20] Eun, Hee Chul (1995).  Evaluation of skin blood flow by laser Doppler 
flowmetry.  Clinics in Dermatology, 13, 337-347.   
[21] Fichera, A.P., D.R. Celander. (1969). Effect of osteopathic 
manipulative therapy on autonomic tone as evidenced by blood pressure 
changes and activity of the fibrinolytic system. Journal of American 
Osteopathic Association. 68:1036-1038. 
[22] Chila, Anthony and the American Osteopathic Association (2010).  
Foundations of Osteopathic Medicine.  Philadelphia, PA: Lippincott Williams & 
Wilkins 
[23] Freccero, Carolin, Frank Holmlund, Siv Bornmyr, Jan Castenfors, Anne-
Marie Johansson, Goran Sundkvist, Henry Svensson, Per Wollmerb. (2003). 
 103 
Laser Doppler perfusion monitoring of skin blood flow at different depths in 
finger and arm upon local heating.  Microvascular research. 66:183-186. 
[24] Fredriksson, Ingemar, Larsson, Marcus, Stromber, Tomas (2009).  
Measurement depth and volume in laser Doppler flowmetry.  Microvascular 
Research 78,  4-13.  doi:10.1016/j.mvr.2009.02.008.   
[25] Foo, Jong Y. A., Lim, Chy S., Wilson, Stephen J. (2009).  
Photoplethysmographic assessment of hemodynamic variations using pulsatile 
tissue blood volume.  Angiology, 59(6), 745-752.  DOI: 
10.1177/0003319708314245 
[26] Fullerton, A, Stocker, M, Wilhelm, K. P., Wardell, K., Anderson, C., 
Fischer, T., Nilsson, G. E., Serup, J. (2002).  Guidelines for visualization of 
cutaneous blood flow by laser Doppler perfusion imaging.  Contact Dermatitis, 
46, 129-140.   
[27] Gevitz, Norman (2001).  Researched and demonstrated: inquiry and 
infrastructure at osteopathic institutions.  Journal of the American Osteopathic 
Association, 101(3), 174-182. 
[28] Gevitz, Norman (2004).  The Dos: Osteopathic Medicine in America.  
Baltimore, MD:  The Johns Hopkins University Press.   
[29] Grim, David, R., Cunningham, Brian M, Burke, Jeanmarie, R. (2005).  
Autonomic nervous system functions among individuals with acute 
musculoskeletal injury.  Journal of Manipulative and Physiological 
Therapeutics, 28(1), 44-51. 
[30] Hall, John E. (2011). Textbook of Medical Physiology.  Philadelphia, 
PA: Saunders Elselvier. 
[31] Henley, Charles E., Douglas Ivins, Miriam Mills, Frances K. Wen, Bruce 
A. Benjamin. (2008). Osteopathic manipulative treatment and its relationship 
to autonomic nervous system activity as demonstrated by heart rate 
variability: a repeated measures study. Osteopathic Medicine and Primary 
Care.  
[32] Hoi, Yiemeng, Wasserman, Bruce A., Xie, Yuanyuan J., Najjar, 
Sammer S., Ferruci, Kuigi, Lakatta, Edward G., Gerstenblith, Gary, Steinman, 
David (2010).  Characterization of volumetric flow rate waveforms at the 
carotid bifurcations of older adults.  Physiological Measurement, 31, 291-302.  
doi:10.1088/0967-3334/31/3/002.   
[33] Holland, Christy, K., Brown, Janis, M., Scoutt, Leslie, M., Taylor, 
Keneth J. W. (1998).  Lower extremity volumetric arterial blood flow in 
normal subjects.  Ultrasound in Medicine and Biology, 24(8), 1079-1086.   
 104 
[34] Howell, Joel D. (1999). The paradox of osteopathy. The New England 
Journal of Medicine. 341(19):1465-1468. 
[35] Hsiu, Hsin, Wei-Chen Hsu, Bo-Hung Chen, Chia-Liang Hsu. Differences 
in the microcirculatory effects of local skin surface contact pressure 
stimulation between acupoints and nonacupoints: possible relevance to 
acupressure. (2010). Physiological Measurement. 31:829-841. 
[36] Hsiu H., C. L. Hsu, C. T. Chen, W. C. Hsu, H. F. Hu, and F. C. Chen 
(2012).  Correlation of harmonic components between the blood pressure and 
photoplethysmography waveforms following local-heating stimulation.  
International Journal of Bioscience, Biochemistry and Bioinformatics, 2(4), 
248-253. 
[37] Humeau, Anne, Benjamin Buard, Guillaume Mah´e, Fran¸cois 
Chapeau-Blondeau, David Rousseau, Pierre Abraham. (2010). Multifractal 
analysis of heart rate variability and laser Doppler flowmetry fluctuations: 
comparison of results from different numerical methods.  Physics in Medicine 
and Biology. 55:6279-6297. 
[38] Jaff, Micheal R. (2002).  Lower extremity arterial disease Diagnostic 
aspects.  Cadiol Clin 20: 491-500. 
[39] Johnson, Shirley M, Kurtz, Margot E. (2001).  Diminished Use of 
Osteopathic Manipulative Treatment and Its Impact on the Uniqueness of the 
Osteopathic Profession.  Academic Medicine, 76(8), 821-828. 
[40] Jowsey, Pete, Jo Perry. (2010). Sympathetic Nervous system effects in 
the hands following a grade III postero-anterior rotator mobilization technique 
applied to T4: A randomized, placebo-controlled trial. Manual Therapy. 30:1-
6. 
[41] Kamal, A. A. R., Harnes, J. B., Irging, G., Mearns, A. J. (1989).  Skin 
photoplethysmography – a review.  Computer Methods and programs in 
Biomedicine, 28, 257-269.   
[42] Karason, Agust B., Drysdale, Ian P. (2003).  Somatovisceral response 
following osteopathic HVLAT:  A pilot study on the effect of unilateral 
lumbosacral high-velocity low-amplitude thrust technique on the cutaneous 
blood flow in the lower limb.  Journal of Manipulative and Physiological 
Therapeutics, 26 (4), 220-225. doi: 10.1016/S0161-4767(02)54110-5. 
[43] Katz, Murray A. (1978).  Dissociation of acetylcholine-induced 
responses of arteriolar resistance vessels and precapillary sphincter-like 
arterioles.  Microvascular Research, 16, 133-140.    
 105 
[44] Kierszenbaum, Abraham L., Tres , Laura L.., (2012).  Histology and 
Cell Biology: An Introduction to Pathology.  Philadelphia, PA:  Elsevier 
Saunders. 
[45] Kilpatrick, D, Johnston, P. R. (1994).  Origin of the electrocardiogram.  
IEEE Engineering in Medicine and Biology, August/September Issue, 479-486. 
[46] King, Hollis H. (2002). Osteopathy in the cranial field:  Uncovering 
challenges and potential applications.  Journal of the American Osteopathic 
Association 107(7), 367-368. 
[47] Knotzer, Hans, Walter R. Hasibeder. (2007). Microcirculatory function 
monitoring at the bedside – a view from the intensive care. Physiological 
Measurement. 28:R65-R68. 
[48] Kvernmo, Hebe Desiree, Stefanovska, Aneta, Kirkeboen, Knut Arvid 
(1999).  Oscillations in human cutaneous blood perfusion signal modified by 
endothelium-dependent and endothelium-independent vasodilators.  
Microvascular Research, 57, 298-309.   
[49] Lefrandt, J.D., E. Bosma, P.H. N. Ooman, J. H. Hoeven, A.M. Room, 
A.J. Smit, K. Hoogenberg. (2003). Sympathetic mediated vasomotion and 
skin capillary permeability in diabetic patients with peripheral neuropathy. 
Diabetologia. 46:40-47. 
[50] Loukas, Marios, Abel, Nicole, Tubbs, Shane R., Grabska, Joanna, 
Birungi, Judith, Anderson, Robert H. (2011).  The cardiac lymphatic system.  
Clinical anatomy 24, 648-691. 
[51] Makin, Inder, Joshua Hope, Deborah Heath(2012).  Development and 
Implementation of a Long-term Multisignal Logging Utility for Peripheral 
Vascular Flow.  Journal of Ultrasound Med. Vol 31. S18-S19.   
[52] Mallini, Alberto, Pagani, Massimo, Lombardi, Federico, Cerutti, Sergio 
(1991).  Cardiovascular neural regulation explored in the frequency domain.  
Circulation, 84(2), 482-492.  doi: 10.1161/01.CIR.84.2.482.   
[53] Miller, Arnold, Evelyn Celander, D.R. Celander, PhD. (1967). Effect of 
soft tissue manipulative therapy and factors regulating blood pressure.  
Journal of American Osteopathic Association. 66:990-991. 
[54] Milnes, Kate, Moran, Robert, W. (2007).  Physiological effects of CV4 
cranial osteopathic technique on autonomic nervous system function:  A 
preliminary investigation.  International Journal of Osteopathic Medicine, 10, 
8-17. 
 106 
[55] Moor Instruments (2009).  Basic theory and operating principles of 
laser Doppler blood flow monitoring and imaging (LDF &LDI), Issue 1.  
Retrieved from www.moor.co.uk. 
[56] Murthy, V.S. I, Sripad Ramamoorthy, Narayanan Srinivasan, Sriram 
Rajagopa, M. Mukunda Rao (2001).  Analysis of photoplethysmographic 
signals of cardiovascular patients.  Proceedings of the 23rd EMBS International 
Conference, October 25-28, Istanbul, Turkey. 
[57] Nitzan, Meir, Babchenko, Anatoly, Khanokh, Boris, Landau, David 
(1998).  The variability of the photoplethysmographic signal – a potential 
method for the evaluation of the autonomic nervous system.  Physiological 
Measurement, 19, 93-102.   
[58] Noll, Donald R., Degenhard, Brian F., Morley, Thomas F., Blais, Francis 
X., Hortos, Kari A., Hensel, Kendi, Johnson, Jane C., Pasta, David J., Stoll, 
Scott T. (2010).  Efficacy of osteopathic manipulation as an adjunctive 
treatment for hospitalized patients with pneumonia:  a randomized controlled 
trial.  Osteopathic Medicine and Primary Care, 4, 1-13. 
[59] Northup, George W. (1979).  Osteopathic Medicine:  An American 
Revolution.  Chicago, IL: American Osteopathic Association. 
[60] Pagani, Massimo, Lombardi, Federico, Guzzettie, Steano, Rimoldi, 
Ornella, Furlan, Raffeallo, Pizzenelli, Paolao, Sandrone, Giulia, Malfatto, 
Gabriella, Dell’Orto, Simonetta, Piccaluga, Emanuela, Turiel, Maurizio, Baselli, 
Guiseppe, Cerutti, Sergio, Malliani, Alberto (1986).  Power spectral analysis of 
heart rate and arterial pressure variabilities as a marker of sympatho-vagal 
interaction in man and conscious dog.  Circulation Research, 59(2), 178-193. 
[61] Perry, Jo, Green Ann (2008).  An investigation into the effects of a 
unilaterally applied lumbar mobilization technique on peripheral sympathetic 
nervous system activity in the lower limbs.  Manual Therapy, 13, 492-499.   
[62] Pizzolorusso, Gianfranco, Turi, Patrizia, Barlafante, Gina, Cerritelli, 
Francesco, Renzetti, Cinzia, Cozzolino, Vincenzo, D’Orazio, Marianna, Fusilli, 
Paola, Carinci, Fabrizio, D’Incecco, Carmine (2011).  Effect of osteopathic 
manipulative treatment on gastrointestinal function and length of stay of 
preterm infants:  an exploratory study.  Chiropractic and Manual Therapies, 
19, 1-6. 
[63] Purdy, W. Randolph DO, Jesse J. Frank, DO, Brent Oliver, DO, PhD. 
(1996). Suboccipital dermatomyotomic stimulation and digital blood flow.  
Journal of American Osteopathic Association. 96(5):285-289. 
 107 
[64] Reaz , M. B. I.,  M. S. Hussain, F. Mohd-Yasin. (2006). Techniques of 
EMG signal analysis: detection, processing, classification and applications. 
Biological Procedures. 8(1):11-35.  
[65] Rhodes, Rodney, Pflanzer, Richard (1996).  Human Physiology, Third 
Edition.  Philadelphia, PA:  Saunders College Publishing. 
[66] Rivers, William Evan, Treffer, Kevin, D., glaros, Alan G., Williams, 
Charlott L. (2008).  Short-term hematologic and hemodynamic effects of 
osteopathic lymphatic techniques:  A pilot crossover trial.  Journal of the 
American Osteopathic Association, 108(11), 646-651. 
[67] Roberts. V. C. (1982).  Photoplethysmography – fundamental aspects 
of the optical properties of blood in motion.  Transactions of the Institute of 
Measurement and Control, 4, 101-106.  DOI: 10.1177/014233128200400205 
[68] Robinson, Brian F., Stephen E. Epstein, G. David Beiser, Eugene 
Braunwald. (1996) Control of heart rate by the autonomic nervous system. 
Circulation Research. 19:400-411. 
[69] Rossi, M., Carpi, A., Galetta, F., Franzoni, F., Santoro, G. (2006).  The 
investigation of skin blood flowmotion:  a new approach to study the 
microcirculatory impairment in vascular diseases?.  Biomedicine and 
Pharmacotherapy, 60, 437-442.   
[70] Rossi, M., A. Carpi, F. Galetta, F. Franzoni, G. Santoro.  (2008).  Skin 
vasomotion investigation:  a useful tool for clinical evaluation of microvascular 
endothelial function?  Biomedicine and Pharmacotherapy 62:  541-545. 
[71] Roustit, M., Blaise, S., Milet, C., Cracowski, J. L. (2010).  Reliability 
and methodological issues of skin post-occlusive and thermal hyperemia 
assessed by the single-point laser Doppler flowmetry.  Microvascular 
Research, 79, 102-108.   
[72] Roustit, Matthieu, Jean-Luc Cracowski (2013).  Assessment of 
endothelial and neurovascular function in human skin microcirculation.  
Trends in Pharmacological Sciences, 34(7):  373-384. 
[73] Shelley, Kirck, H (2007).  Photoplethysmography:  Beyond the 
calculation of arterial oxygen saturation and heart rate.  Anesthesia and 
Analgesia, 105(6), S31-S36.   
[74] Shibasaki, Manabu, Ramussen, Peter, Secher, Niels, Crandall, Craig 
(2009)  Heural and non-neural control of skin blood flow during isometric 
handgrip exercise in the heat stressed human.  Journal of Physiology, 587.9: 
2101-2107. 
 108 
[75] Still, Andrew Taylor (1908).  Autobiography of Andrew T. Still – with a 
history of the discovery and development of the science of osteopathy.  Self-
published.  Kirksville, Mo. 
[76] Su, Yi-Ju, Wan-An Lu, Gau-Yang Chen, Margaret Liu, Hsiang-Tai Chao 
& Cheng-Deng Kuo (2011).  Power spectral analysis of plethysmographic 
pulse waveform in pregnant women.  Journal of Clinical Monitoring and 
Computing, 25(3), 183-191.  DOI 10.1007/s10877-011-9291-3. 
[77] Tozzi, Paulo (2012)  Selected fascial aspects of osteopathic practice.   
Journal of Bodywork and Movement Therapies, 16:  503-519. 
doi:10.1016/j.jbmt.2012.02.003. 
[78] Traikov, Lubomir, I. Antonov, J. Petrova. (2011). Signal processing 
and wavelet analysis of simultaneously registered blood pressure and laser 
Doppler flow signals during extremely low frequency electromagnetic field 
exposure in humans in vivo. Environmentalist. 31:187-195. 
[79] Voigt, Karen, Liebnitzky, Jan, Burmeister, Ute, Shivonen-
Riemenschneider, Henna, Beck Matthias, Voigt, Roger, Bergnamm, Anjte 
(2011).  Efficacy of osteopathic manipulative treatment of female patients 
with migrane:  Results of a randomized controlled trial.  The Journal of 
alternative and complementary medicine, 17(3), 225-230. 
[80] Walkowski, Stevan, Singh Manindra, Puertas,  Juan, Pate, Michelle, 
Goodrum, Kenneth, Benecia Fabian (2014).  Osteopathic manipulative 
therapy induces early plasma cytokine release and mobilization of a 
population of blood dendritic cells.  Immune Parameters and Osteopathic 
Manipulation, 9(3), 1-12. 
[81] Wallin, Gunnar B. (1990).  Neural control of human skin blood flow.  
Journal of the Autonomic Nervous System, 30, S185-S190. 
[82] Wu, Mingyuan, Bengt Linderoth, Robert D. Foreman. (2008). Putative 
Mechanisms behind effects of spinal cord stimulation on vascular diseases: A 
review of experimental studies. Autonomic Neuroscience: Basic and Clinical. 
138:9-23. 
[83] Young, Barbara, O'Dowd, Geraldine, Woodford Phillip (2014).  
Wheater’s Functional Histology:  A Text and Colour Atlas.  Sixth Edition.  
Philadelphia, PA: Churchill Livingstone. 
[84] Zegarra-Parodi ,Rafael, Park ,Peter Yong Soo, Heath, Deborah M., 
Makin, Inder Raj S., Degenhardt, Brian F., Roustit, Matthieu (2014).  
Assessment of skin blood flow following spinal manual therapy: A systematic 
review.  Manual Therapy,XXX,1-22. 
 
 109 
APPENDIX A  
IRB APPROVAL  
 110 
IRB Approval 
 
 
DATE:  September 20, 2010 
 
TO:  Deborah M. Heath, DO 
  Inder Makin, MD, PhD 
   
FROM: ATSU-Mesa IRB Committee 
 
SUBJECT: Research Proposal, IRB tracking #2010-80 
 
 
 
Thank you for the opportunity to review the research proposal, Investigation of Peripheral 
Blood Flow Response to Provocation Tests Including Osteopathic Digital Pressure on 
Vertebral Segments. 
 
After reviewing the proposal, the ATSU-Mesa IRB committee believes that this proposal 
meets the minimal risk guidelines established by A.T. Still University of Health Sciences. 
Thank you for your time and attention to detail in completing the IRB proposal submission 
process. You may now proceed with data collection.  
 
If any changes are made to the protocol following this approval, you must complete and 
submit the request for changes form located on the IRB website. 
 
If you have any questions, please feel free to call or write. 
 
Respectfully, 
 
 
 
Curt Bay, PhD 
Chair, ATSU-Mesa Institutional Review Board 
Arizona School of Health Sciences 
A.T. Still University 
5850 East Still Circle 
Mesa, AZ  85206 
Main:  (480) 219-6000 
Office: (480) 219-6037 
rcbay@atsu.edu 
 
 
  
 111 
APPENDIX B 
OMITTED SESSIONS 
  
 112 
Table 12:  Table of Experimental Trials:  This table shows the active group, control group 
and provides descriptor on which sessions were omitted from analysis. 
Sessi
on # 
"Sub
j. #" 
Date Initia
ls 
Gend
er 
Ag
e 
Subject 
Set Up 
Omissio
n 
Experim
ental 
Group 
1 "5" 5/18/1
0 
AM M 30 Active 
provocation 
Short 
Session 
NA 
2 "6" 5/25/1
0 
MG F 30 Active 
provocation 
Short 
Session 
NA 
3 "7" 6/01/1
0 
DR F 58 No 
provocation  
C 
4 "8" 6/02/1
0 
TH F 33 Occlusion 
and 
Hyperthermi
a Only 
Short 
Session, 
broken 
LDF lead, 
Systemic 
stimuli 
Session 
only 
NA 
5 "9" 8/03/1
0 
DR* F 58 Active 
provocation 
Short 
Session 
NA 
6 "10" 8/04/1
0 
MG* F 30 Active 
provocation 
Short 
Session, 
OMT only 
session 
NA 
7 "11" 8/10/1
0 
RB M 28 Active 
provocation  
A 
8 "12" 8/11/1
0 
TH* F 33 No 
Provocation  
C 
9 "13" 8/17/1
0 
SW F 28 Active 
provocation  
A, Rp 
10 "14" 8/18/1
0 
KS F 29 Active 
provocation  
A, Rp, Rc 
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Sessi
on # 
"Sub
j. #" 
Date Initia
ls 
Gend
er 
Ag
e 
Subject 
Set Up 
Omissio
n 
Experim
ental 
Group 
11 "15" 9/22/1
0 
TH** F 33 Active 
provocation 
Broken 
Lead 
NA 
12 "16" 11/09/
10 
CN M 19 Active 
Provocation  
A 
13 "17" 02/02/
11 
"SW*
" 
F 28 Active 
Provocation 
R "Subj 
13"  
A, Rp 
14 "18" 02/15/
11 
"CN*" M 19 Active 
Provocation 
R "Subj 
16"  
A 
15 "19" 02/21/
11 
"KS*" F 29 Active 
Provocation 
R "Subj 
14"  
A, Rp, Rc 
16 "20" 05/18/
11 
JF F 42 Active 
Provocation  
A, Rc 
17  "21" 07/18/
11 
JF* F 42 No 
Provocation  
C 
18 "22" 08/09/
11 
JF-N F 39 Active 
Provocation  
A, Rc 
19 "23" 09/21/
11 
LW F 39 Active 
Provocation  
A, Rc 
20 "24" 09/23/
11 
TJJr M 34 Active 
Provocation  
A, Rp 
21 "25" 09/26/
11 
RC F 24 Active 
Provocation  
A 
22 "26" 04/04/
12 
KH F 54 Baseline 
Only  
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Sessi
on # 
"Sub
j. #" 
Date Initia
ls 
Gend
er 
Ag
e 
Subject 
Set Up 
Omissio
n 
Experim
ental 
Group 
23 "27" 04/09/
12 
VD F 56 Baseline 
Only 
Outlier in 
hemodyn
amic 
response 
NA 
24 "28" 04/17/
12 
"LW*" F 40 Baseline 
Only R 
"Subj 23"  
C 
25 "29" 04/24/
12 
"DH" F 54 Baseline 
Only  
C 
26 "30" 05/11/
12 
"KH"* F 54 Active 
provocation 
Noisy 
data due 
to sensor 
and hand 
positionin
g 
A 
27 "31" 10/29/
12 
"JL" F 34 Baseline 
Only  
C 
28 "32" 11/09/
12 
"JL*" F 34 Active 
Provocation 
R "Subj 
31"  
A 
29 "33" 05/08/
13 
"BJ" F 33 Baseline 
Only  
C 
30 "34" 05/24/
13 
"BJ"* F 33 Active 
session  
A 
31 "35" 08/07/
13 
"JM" M 41 Baseline 
Only  
C 
32 "36" 08/12/
13 
"JM*" M 41 "Simulatio
n" Session 
Sham 
Session 
NA 
33 "37" 08/14/
13 
"JM**
" 
M 41 Active 
session  
A, Rc 
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Sessi
on # 
"Sub
j. #" 
Date Initia
ls 
Gend
er 
Ag
e 
Subject 
Set Up 
Omissio
n 
Experim
ental 
Group 
34 "38" 08/17/
13 
"WM" F 51 Baseline 
session  
C 
35 "39" 08/19/
13 
"WM*
" 
F 51 Active 
session 
 A 
36 "40" 08/21/
13 
"WM*
" 
F 51 Baseline 
session R 
"Subj 38" 
 C 
 
Table 13:  Biopac Sessions recorded and omitted 
 Control Active Total 
Sessions Recorded 13 23 36 
Omitted  2 7 9 
Total Sessions 
Used 11 16 27 
 
The Omitted session descriptions are as follows: 
Sessions 5, 6, 9 and 10 and were considered “short” sessions by the clinician, while 
the latter sessions were termed “long” sessions, where the terms “short” and “long” refer to 
the intensity and duration of the OMT application. Short sessions had lesser in intensity and 
duration as compared to the longer sessions.  The short sessions occurred early on in the 
study, and after preliminary analysis it was concluded that the “short” sessions yield results 
similar to the control sessions.  In the long sessions the clinician performed the OMT as it 
would be done on symptomatic subjects, and therefore augmented the results in the raw 
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data and clinical assessment.  This suggests a time dependent threshold, physiologically.  
For the purpose of this study, the “short” sessions were excluded from the analysis.   
Session 8 and 15 were omitted due to broken leads.   
Session 30 was omitted because it was too noisy to be utilized in post processing.  
It was determined that the position of the subjects hands were face down during the session 
which caused a disturbance with the sensors.  In all other sessions the positions of subjects’ 
hands were face up, and therefore this disturbance to the sensors was not present.  The 
disturbances include pressure to the vessels in the finger pulp causing distortion of the 
signal, or saturated readings where part of the signal is lost due to clipping, and 
misalignment on the finger pulp causing  
Session 10 is an OMP only session, where the first half of the session is baseline 
only and the last half of the session is the same as the active session, so that only the last 
four provocations were performed.  This study was considered a “short” session and was 
therefore excluded from analysis.  Session 8 is a non-OMP session, where only the first 
three systemic provocations were performed, but no OMPs were performed.  However, this 
session had a broken lead and was therefore excluded from analysis. 
Subject 27 is an atypical session.  All control and active sessions show that the 
increases in peak to peak value of PPG simultaneously occur with increases in DC value of 
the LDF signal.  And throughout the session for Subject 27, a baseline session, the blood 
flow and blood volume increased, rather than the decreasing trend found in all other control 
sessions and some active sessions.  Active sessions, specifically responders, did increase if 
not maintain the signal levels throughout the session.  Testing on instrumentation was 
completed after the session and it was determined that the instrumentation was working 
appropriately.  See sit and standing test in the appendix.  Since Subject 27 did not display 
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the typical behavior it was excluded from the analysis.  Further research is required in order 
to determine the reasons for this atypical behavior.   Further subjects are required to 
determine how common this atypical behavior is.   
Subject 27 Outlier Control Session  
 
Subject 07 Typical Control Session 
 
Figure 50:  Subject 27 Control Session (left) showing reverse hemodynamics compared to 
all other control sessions, Subject 07 (right) representative control session.  Subject 27 was 
omitted from the final analysis as it was an outlier in hemodynamic response for control 
sessions. 
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Table 14: 
Biopac Hardware and Instrumentation 
 Hardware Connection Model/Serial No. 
A 3-lead EKG sensor Master DAQ Box Ch1 SSL2 Electrode 
705A1396 
B Room Temp sensor Master DAQ Box Ch2 SS6L FAST TEMP 
SN9085138 
C LtPPG sensor Slave DAQ Box Ch1 SS4LA Pulse 
SN7054738    
D LtLDF Sensor LtLDF Signal Conditioner 
Box 
TSD140 SN PR91322 
E Cable from LtLDF Sign al 
Conditioner to Slave DAQ 
Box 
Analog Channel 1 to 
Slave DAQ Box Ch 2 
BSLCBL14 UIM/IPS-
MP35 SN609 0120    
F RtPPG Slave DAQ Box Ch3 SS4LA Pulse 
SN7054738    
G RtLDF Sensor RtLDF Signal 
Conditioner Box 
TSD140 SN PR91302 
H Cable from RtLDF Signal 
Conditioner Box to Slave 
DAQ Box 
Analog Channel 1 to 
Slave DAQ Box Ch4 
BSLCBL14 UIM/IPS-
MP35 SN812 0134 
I Cable Master to Slave 
DAQ Box  
“Analog Output” on 
Master to “Trigger” BNC 
input on Slave 
OUT2 BNC SN602179 
J Master DAQ Box Master PC via Biopac 
MP35 USB cable 
MP35 SN 
MP35A70103726 
K Slave DAQ Box Slave PC via Biopac 
MG35 USB cable 
MP35 SN 
MP35A70103715 
L Lt Signal Conditioner Box NA LDF100C model 
IPS100C-1 SN 
IPS810C0000290 
M Rt Signal Conditioner Box NA LDF100C model 
IPS100C-1 SN 
IPS810C0000284 
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Acquisition-Sampling  
 
 
PPF-Filter-HW-Scaling 
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PPG and LDF Filter-HW-Scaling  
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Data Acquisition System Test      DATE:  26 September 2011 
DAQ system check was performed.  The raw data from today’s sessions indicated nearly an 
order of magnitude difference between the right and left side.  The first two tests were 
performed to ensure that the right and left sensors, for both PPG and LDF, were 
independent.  We confirmed that the PPG and LDF signals were independent.  The raw data 
also show a slow wave signal in the LDF data, whereas the PPG data does not have this slow 
wave.  Therefore, the third test conducted was to test the high pass filter on the PPG 
software setting.  The filter was reduced form the default software setting of 0.5 Hz to 
0.05Hz.  The raw PPG data did show the slow wave after high pass filter setting was 
reduced.    
1. PPG Systemic Check | Subject:  IM 
This test was performed to check if the right and left PPG sensors were appropriately 
measuring data correctly.  The PPG sensors were attached to the index fingers.  Data was 
acquired for approximately two min.  Then the channels were swapped and data was 
acquired again.  The channels were swapped back to the original configuration.  Each time, 
data was acquired for approximately 2 min.  Regardless of configuration, the left side was 
always greater in magnitude than the right side.  Thus, the sensors were independent. 
- Run1: Left finger  on Ch1  >  Right finger on Ch3 
- Run 2: Left finger on Ch3   >  Right finger on Ch1 
- Run 3: Left finger on Ch1   >  Right finger on Ch3     
 
2. LDF Systemic Check | Subject: IM 
This test was performed similarly to the PPG systemic test described above.  The LDF 
sensors, however, were attached to the middle fingers.  NOTE: the PPG sensors were not 
removed.  The raw data will show that all four sensors are activated.  Regardless of 
configuration, the right and left side were within the same range.   Thus, the sensors were 
independent. 
- Run 1: Left finger  on Ch2  =  Right finger on Ch4 
- Run 2:  Left finger on Ch4   =  Right finger on Ch2 
- Run3: Left finger on Ch2   =  Right finger on Ch4     
 
3. High Pass Filter System Test | Subject: IM 
Data was first acquired with the default HPF setting.  Then it was reduced.  Then it was 
restored to the default setting again.  The slow wave was apparent with the reduced filter, 
and was not apparent with the default.  Each acquisition was approximately two minutes.    
- Run 1: SW setting on HPF = 0.5Hz  :   No Slow wave 
- Run2: SW setting on HPF = 0.05Hz:  Slow wave arises 
- Run3: SW setting on HPF = 0.5Hz  : No Slow wave 
It remains to be determined if the HPF setting will remain at 0.5Hz or reduced to 0.05Hz for 
subsequent sessions.  If the cutoff frequency is reduced, the data can be post processed 
through a HPF moving the cutoff frequency back to 0.5Hz.  In this way the extra low 
frequency data can be acquired and used for analysis if found to be useful.    
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Table 15:  Biopac ACQKnowledge Heart Rate Variability Output 
1. RR Interval 
 
2. Interpolated RR on 
 
3. Spectrum 
 
HRV Analysis, CH1, ECG (.5 - 35 
Hz)  
RR Intervals 
0.84 
0.855 
0.775 
0.775 
0.845 
0.85 
0.835 
0.825 
0.845 
Power in the very low 
frequency band: 1.39E-07 sec^2/Hz 
 Power in the low frequency 
band: 5.15E-07 sec^2/Hz 
 Power in the high frequency 
band: 1.23E-06 sec^2/Hz 
 Power in the very high 
frequency band: 4.42E-06 sec^2/Hz 
 Sympathetic: 0.295729 
  Vagal: 0.704271 
  Sympathetic-vagal balance: 0.419907 
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Mann-Whitney U test 
The Mann-Whitney U test using IBM SPSS software was used to test the significance of the 
data. The Mann-Whitney U test ranks the samples from all groups in order from smallest to 
large.  It then compares the mean rank order from each group.  A z-test is then used to 
determine the if the means of the rank order are significantly different.  We cannot reject 
the null hypothesis if p value is greater than alpha.  Alpha is 0.05  or 0.01. 
Time Domain statistical analysis was completed for phase by phase comparison across the 
groups :  Data for the analysis are found in the following file: TimeStats with Summary 
2014 10 09 copy for Statistical Analysis.xlsx 
Table 16:  Statistical Analysis methods 
Analysis Groupings Data Set 
Between 
group analysis 
Phase 7-15 of: 
1) Control to Active 
2) Control to Peripheral 
Responder 
3) Control to Central 
Responder 
1) Left PPG RMS 
2) Right PPG RMS 
3) Left LDF RMS 
4) Right LDF RMS 
5) Left Volume-Flow RMS 
6) Right Volume Flow RMS 
7) Heart Rate 
 
Frequency Domain statistical analysis was completed for phase by phase comparison across 
the groups:  Data for the analysis are found in the following file:  FrequencyStats with 
Summary 2014 10 09 copy for Statistical Analysis.xlsx 
Analysis Groupings Data Set 
Between 
group analysis 
1) Control to Active 
2) Control to Peripheral 
Responder 
3) Control to Central 
Responder 
1) Lt PPG Range 1 [0-0.5Hz] 
2) Rt PPG Range 1 [0-0.5Hz] 
3) Lt PPG Range 2 [0.5 – 1.5 Hz] 
4) Rt PPG Range 2 [0.5-1.5 Hz] 
5) Lt PPG Range 3 [1.5 – 3 Hz] 
6) Rt PPG Range 3 [1.5-3 Hz] 
7) Lt LDF Range 1 [0-0.5Hz] 
8) Rt LDF Range 1 [0-0.5Hz] 
9) Lt LDF Range 2 [0.5 – 1.5 Hz] 
10) Rt LDF Range 2 [0.5-1.5 Hz] 
11) Lt LDF Range 3 [1.5 – 3 Hz] 
12) Rt LDF Range 3 [1.5-3 Hz] 
 
Null Hypothesis = means are not different, Alternative Hypothesis = means are different. 
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Statistical Analysis using Parametric Test 
Time Domain statistical analysis was completed for mean trend comparison between 
groups:  Data for the analysis are found in the following file:  TimeStats with Summary 
2014 10 09 copy for Statistical Analysis.xlsx 
Table 17:  Statistical Analysis methods 
Analysis Groupings Data Set 
Between 
group analysis 
Mean Trend of  Phase 7-15 of: 
1) Control to Active 
2) Control to Peripheral 
Responder 
3) Control to Central 
Responder 
1) Left PPG RMS 
2) Right PPG RMS 
3) Left LDF RMS 
4) Right LDF RMS 
5) Left Volume-Flow RMS 
6) Right Volume Flow RMS 
7) Heart Rate 
 
Frequency Domain statistical analysis was completed for mean trend comparison 
between groups:  Data for the analysis are found in the following file: 
FrequencyStats with Summary 2014 10 09 copy for Statistical Analysis.xlsx 
Analysis Groupings Data Set 
Between 
group analysis 
Mean Trend of  Phase 7-15 of: 
1) Control to Active 
2) Control to Peripheral 
Responder 
3) Control to Central 
Responder 
1) Lt PPG Range 1 [0-0.5Hz] 
2) Rt PPG Range 1 [0-0.5Hz] 
3) Lt PPG Range 2 [0.5 – 1.5 Hz] 
4) Rt PPG Range 2 [0.5-1.5 Hz] 
5) Lt PPG Range 3 [1.5 – 3 Hz] 
6) Rt PPG Range 3 [1.5-3 Hz] 
7) Lt LDF Range 1 [0-0.5Hz] 
8) Rt LDF Range 1 [0-0.5Hz] 
9) Lt LDF Range 2 [0.5 – 1.5 Hz] 
10) Rt LDF Range 2 [0.5-1.5 Hz] 
11) Lt LDF Range 3 [1.5 – 3 Hz] 
12) Rt LDF Range 3 [1.5-3 Hz] 
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Spectral Doppler ultrasound Quick Assessment Tool 
A quick analysis tool was developed using Matlab interactive GUI.  This tool was 
developed for the purpose of providing a quick analysis in a clinical setting.  The GUI is 
shown in Figure 51 
 
Figure 51:  Doppler Project Quick Analysis Took GUI. 
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Percent change Tables 
Table 18:  Tables of increase and decrease for PPG, LDF, Volume, Left and Right 
hands 
PPG 
RMS 
Left 
              Control  (n=11) Active (n=16) P. Resp (n=5) C. Resp (n=6) 
  Dec Inc NC Dec Inc NC Dec Inc NC Dec Inc NC 
Initial 
to 
Final 100.0% 
0.0
% 
0.0
% 
100.0
% 
0.0
% 
0.0
% 
100.0
% 0.0% 
0.0
% 
100.0
% 0.0% 
0.0
% 
OA-
C2 63.6% 
27.3
% 
9.1
% 
31.3
% 
56.3
% 
12.5
% 
20.0
% 
80.0
% 
0.0
% 
33.3
% 
50.0
% 
16.7
% 
T1-T4 63.6% 
9.1
% 
27.3
% 
50.0
% 
37.5
% 
12.5
% 
40.0
% 
40.0
% 
20.0
% 
33.3
% 
50.0
% 
16.7
% 
T8-L2 72.7% 
18.2
% 
9.1
% 
25.0
% 
50.0
% 
25.0
% 0.0% 
100.0
% 
0.0
% 
16.7
% 
66.7
% 
16.7
% 
L5-S 36.4% 
18.2
% 
45.5
% 
31.3
% 
43.8
% 
25.0
% 
20.0
% 
60.0
% 
20.0
% 0.0% 
66.7
% 
33.3
% 
             PPG RMS Right 
             Control  (n=11) Active (n=16) P. Resp (n=5) C. Resp (n=6) 
  Dec Inc NC Dec Inc NC Dec Inc NC Dec Inc NC 
Initial to 
Final 
100.0
% 
0.0
% 
0.0
% 
81.3
% 
12.5
% 
6.3
% 
40.0
% 
40.0
% 
20.0
% 
66.7
% 
16.7
% 
16.7
% 
OA-C2 
54.5
% 
18.2
% 
27.3
% 
50.0
% 
43.8
% 
6.3
% 
40.0
% 
60.0
% 
0.0
% 
33.3
% 
50.0
% 
16.7
% 
T1-T4 
54.5
% 
18.2
% 
27.3
% 
50.0
% 
31.3
% 
18.8
% 
40.0
% 
40.0
% 
20.0
% 
50.0
% 
50.0
% 
0.0
% 
T8-L2 
54.5
% 
18.2
% 
27.3
% 
25.0
% 
56.3
% 
18.8
% 0.0% 
100.0
% 
0.0
% 
16.7
% 
66.7
% 
16.7
% 
L5-S 
45.5
% 
27.3
% 
27.3
% 
31.3
% 
62.5
% 
6.3
% 0.0% 
80.0
% 
20.0
% 0.0% 
100.0
% 
0.0
% 
             
             LDF RMS 
Left 
              Control  (n=11) Active (n=16) P. Resp (n=5) C. Resp (n=6) 
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  Dec Inc NC Dec Inc NC Dec Inc NC Dec Inc NC 
Initial to 
Final 
100.0
% 
0.0
% 
0.0
% 
81.3
% 
12.5
% 
6.3
% 
60.0
% 
20.0
% 
20.0
% 
83.3
% 0.0% 
16.7
% 
OA-C2 
63.6
% 
36.4
% 
0.0
% 
37.5
% 
50.0
% 
12.5
% 0.0% 
80.0
% 
20.0
% 
16.7
% 
50.0
% 
33.3
% 
T1-T4 
72.7
% 
18.2
% 
9.1
% 
56.3
% 
25.0
% 
18.8
% 
20.0
% 
40.0
% 
40.0
% 
66.7
% 
33.3
% 
0.0
% 
T8-L2 
72.7
% 
18.2
% 
9.1
% 
37.5
% 
37.5
% 
25.0
% 0.0% 
100.0
% 
0.0
% 
50.0
% 
33.3
% 
16.7
% 
L5-S 
72.7
% 
18.2
% 
9.1
% 
50.0
% 
43.8
% 
6.3
% 
20.0
% 
80.0
% 
0.0
% 
33.3
% 
66.7
% 
0.0
% 
             LDF RMS Right 
             Control  (n=11) Active (n=16) P. Resp (n=5) C. Resp (n=6) 
  Dec Inc NC Dec Inc NC Dec Inc NC Dec Inc NC 
Initial to 
Final 
100.0
% 
0.0
% 
0.0
% 
87.5
% 
12.5
% 
0.0
% 
60.0
% 
40.0
% 
0.0
% 
83.3
% 
16.7
% 
0.0
% 
OA-C2 
63.6
% 
18.2
% 
18.2
% 
43.8
% 
50.0
% 
6.3
% 0.0% 
80.0
% 
20.0
% 
33.3
% 
50.0
% 
16.7
% 
T1-T4 
54.5
% 
27.3
% 
18.2
% 
50.0
% 
31.3
% 
18.8
% 0.0% 
60.0
% 
40.0
% 
50.0
% 
33.3
% 
16.7
% 
T8-L2 
45.5
% 
27.3
% 
27.3
% 
37.5
% 
50.0
% 
12.5
% 0.0% 
100.0
% 
0.0
% 
50.0
% 
50.0
% 
0.0
% 
L5-S 
54.5
% 
27.3
% 
18.2
% 
56.3
% 
31.3
% 
12.5
% 0.0% 
80.0
% 
20.0
% 
50.0
% 
33.3
% 
16.7
% 
             
             
             
Volume RMS -Left 
             Control  (n=11) Active (n=16) P. Resp (n=5) C. Resp (n=6) 
  Dec Inc NC Dec Inc NC Dec Inc NC Dec Inc NC 
Initial to 
Final 
100.0
% 
0.0
% 
0.0
% 
100.0
% 
0.0
% 
0.0
% 
100.0
% 0.0% 
0.0
% 
100.0
% 0.0% 
0.0
% 
OA-C2 
63.6
% 
36.4
% 
0.0
% 
31.3
% 
50.0
% 
18.8
% 0.0% 
80.0
% 
20.0
% 
16.7
% 
50.0
% 
33.3
% 
T1-T4 
54.5
% 
18.2
% 
27.3
% 
50.0
% 
31.3
% 
18.8
% 
20.0
% 
40.0
% 
40.0
% 
50.0
% 
50.0
% 
0.0
% 
 134 
T8-L2 
81.8
% 
18.2
% 
0.0
% 
37.5
% 
43.8
% 
18.8
% 0.0% 
100.0
% 
0.0
% 
33.3
% 
50.0
% 
16.7
% 
L5-S 
63.6
% 
27.3
% 
9.1
% 
50.0
% 
43.8
% 
6.3
% 
40.0
% 
60.0
% 
0.0
% 
33.3
% 
66.7
% 
0.0
% 
             Volume RMS -Right 
             Control  (n=11) Active (n=16) P. Resp (n=5) C. Resp (n=6) 
  Dec Inc NC Dec Inc NC Dec Inc NC Dec Inc NC 
Initial to 
Final 
100.0
% 
0.0
% 
0.0
% 
81.3
% 
18.8
% 
0.0
% 
40.0
% 
60.0
% 
0.0
% 
66.7
% 
33.3
% 
0.0
% 
OA-C2 
81.8
% 
18.2
% 
0.0
% 
50.0
% 
43.8
% 
6.3
% 
20.0
% 
60.0
% 
20.0
% 
50.0
% 
50.0
% 
0.0
% 
T1-T4 
63.6
% 
18.2
% 
18.2
% 
50.0
% 
31.3
% 
18.8
% 
20.0
% 
40.0
% 
40.0
% 
50.0
% 
50.0
% 
0.0
% 
T8-L2 
54.5
% 
18.2
% 
27.3
% 
43.8
% 
50.0
% 
6.3
% 0.0% 
100.0
% 
0.0
% 
50.0
% 
50.0
% 
0.0
% 
L5-S 
72.7
% 
27.3
% 
0.0
% 
50.0
% 
50.0
% 
0.0
% 
20.0
% 
80.0
% 
0.0
% 
16.7
% 
83.3
% 
0.0
% 
 
